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Background: The mechanism involved in activity-dependent survival of neurons in the central nervous system is not fully
understood.
Results:Nurr1 is involved in excitatory transmission-dependent survival of glutamatergic neurons by acting downstreamCREB
and upstream of BDNF.
Conclusion: Nurr1 activation mediates activity-dependent survival of glutamatergic neurons.
Significance: A novel function of Nurr1 in activity-dependent survival of glutamatergic neurons is reported.
NMDAreceptor (NMDAR) stimulationpromotesneuronal sur-
vival during brain development. Cerebellar granule cells (CGCs)
need NMDAR stimulation to survive and develop. These neurons
differentiate and mature during its migration from the external
granular layer to the internal granular layer, and lack of excitatory
inputs triggers their apoptotic death. It is possible to mimic this
process in vitro by culturing CGCs in low KCl concentrations (5
mM) in thepresenceor absenceofNMDA.Using this experimental
approach, we have obtained whole genome expression profiles
after 3 and 8 h of NMDA addition to identify genes involved in
NMDA-mediatedsurvivalofCGCs.Oneof the identifiedgeneswas
Nurr1, a member of the orphan nuclear receptor subfamily Nr4a.
Our results report a direct regulation of Nurr1 by CREB after
NMDAR stimulation. ChIP assay confirmed CREB binding to
Nurr1promoter,whereasCREBshRNAblockedNMDA-mediated
increase in Nurr1 expression. Moreover, we show that Nurr1 is
important for NMDAR survival effect. We show that Nurr1 binds
toBdnf promoter IV and that silencingNurr1 by shRNA leads to a
decrease in brain-derived neurotrophic factor (BDNF) protein lev-
els and a reduction of NMDA neuroprotective effect. Also, we
report that Nurr1 and BDNF show a similar expression pattern
during postnatal cerebellar development. Thus, we conclude that
Nurr1 is a downstream target ofCREBand that it is responsible for
theNMDA-mediated increase inBDNF,which is necessary for the
NMDA-mediated prosurvival effect on neurons.
During brain development, neuronal activity suppresses apo-
ptosis and promotes survival of neurons, adjusting neuronal
population to its connection patterns. The role of the NMDA
subtype of glutamate receptors (NMDAR)5 supporting neuro-
nal survival during CNS development is well documented, and
it has been reported that basal NMDAR activity suppresses
neuronal apoptosis in the somatosensory thalamus, the hypo-
thalamus, and the dentate gyrus and in CA1 in the hippocam-
pus, among other brain areas (1–3). The trophic effect of
NMDAR stimulation is especially necessary for the survival and
differentiation of cerebellar granule cells (CGCs) (4).
CGCs are generated during the postnatal development of the
cerebellum in the external granule layer and migrate to the
internal granule layer to becomemature CGCs (5, 6). During its
migration, they need glutamatergic stimulation from themossy
fibers. The stimulation of NMDAR is necessary for the mainte-
nance of these neurons during cerebellum development (7–9).
Failure to receivemossy fiber inputs will drive CGCs to apopto-
tic death (10, 11). This scenario can be mimicked in vitro in
primary cultures of CGCs. When these neurons are grown in
low potassium concentration (5 mM KCl; K5), they undergo
spontaneous apoptosis. Nevertheless, they will develop and
survive in the presence of high potassium concentrations (25
mM KCl; K25) or NMDA (4, 12, 13).
It has been widely reported that the activation of survival
signaling kinases, including Akt and ERK (14, 15), and the sup-
pression of proapoptotic kinases, such as glycogen synthase
kinase-3 (GSK-3) or JNK (16, 17), are involved in neuronal
survival. The regulation of these kinases modulates the activity
of some transcription factors that control the expression of pro-
and antiapoptotic genes. In CGCs, NMDA-mediated prosur-
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vival effect seems to be dependent on the activation of the phos-
phatidylinositol 3-kinase (PI3K)/Akt pathway (13, 18) and the
activation of CREB (19). Other transcription factors, for exam-
ple MEF2, FKHRL1, DeltaNp73, or Sp1/3, have also been
reported to be involved in neuronal survival (20–23). However,
whether these or other factors are involved in the signaling
related to the NMDAR-mediated prosurvival effect is still
poorly understood.
In the present study, we have analyzed the expression
changes in response to NMDA treatment in cultured CGCs. By
comparative analysis, we have identified Nurr1 as a candidate
tomediate theNMDARprosurvival response. In fact, we report
that NMDA induction of CREB activation promotes Nurr1
expression and consequent up-regulation of its protein levels.
In addition, silencing of Nurr1 results in a reduction in brain-
derived neurotrophic factor (BDNF) levels that correlates with
the decrease in the NMDA-mediated neuroprotection in these
cells.
EXPERIMENTAL PROCEDURES
Cell Culture—Granule cell cultures were prepared from dis-
sociated cerebella of 8-day-old Wistar rats as described previ-
ously (4). Cells were plated (3 103 cells/mm2) in Eagle’s basal
medium (Sigma-Aldrich) and 5 or 25 mM KCl (K5, K25) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS,
Sigma-Aldrich), 25,000 units of penicillin, and 25 mg of strep-
tomycin (PAN Biotech Inc.). 10 M cytosine--D-arabino-
furanoside was added to the cultures 24 h after plating to pre-
vent proliferation of non-neuronal cells. Neurons were plated
onto poly-L-lysine coated 48-well plates for measurement of
cell viability and immunocytochemistry, on 35-mm culture
dishes for RNA extraction and Western blotting, on 24-well
plates for luciferase assays, and on 100-mm plates for ChIP
assays. At 2 days in vitro (DIV), K5 neurons were treated or not
with NMDA (100 M, Sigma-Aldrich) or K25. The procedures
followed were in accordance with guidelines of the Comissió
d’Ètica en l’Experimentació Animal i Humana of the Universi-
tat Autònoma de Barcelona.
Cell Viability—Neuronal viability was assessed using the
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bro-
mide (MTT) assay. Cells were incubatedwithMTT (0.2mg/ml)
for 45 min at 37 °C. The blue formazan derivative was solubi-
lized in 100 l of dimethyl sulfoxide, and the dual wavelength
was measured at 560 and 620 nm in a Labsystems Multiskan
plate reader. Data are presented as mean  S.E. of values
obtained from three or four independent experiments per-
formed in triplicates.
Fluorescence Analysis of Apoptotic Nuclei—Apoptosis was
assessed by nuclear DNA staining with Hoechst 33258. Cells
were washed twice in Tris-buffered saline (TBS) 24 h after the
treatment, fixed with 4% paraformaldehyde in phosphate-buff-
ered saline (PBS) for 45 min at 4 °C, and stained with 1 g/ml
Hoechst 33258 (Molecular Probes) for 5min after beingwashed
again twice inTBS.NuclearDNAstainingwas observedwith an
inverted microscope (Nikon eclipse TE-2000-E). In every
experiment, more than 1000 cells were individually examined
for each experimental condition. Condensed and/or frag-
mented nuclei were considered as apoptotic nuclei. Data are
given as mean  S.E. of values obtained in three or four inde-
pendent experiments performed in triplicate. Results are
expressed as the percentage of apoptotic nuclei versus total
nuclei.
Immunoblotting—CGC cultures were washed with PBS, and
total proteinwas extracted by incubating neurons in lysis buffer
containing 20mMTris, pH 7.5, 1%Nonidet P-40, 150mMNaCl,
5 mM EDTA, 1 mM PMSF, 10 g/ml aprotinin, 20 g/ml leu-
peptin, 1 mM activated orthovanadate. Cell lysates were soni-
cated for 1 min. Proteins (25 g) were resolved in 10% SDS-
PAGE gel and transferred to nitrocellulose membranes
(Amersham Biosciences). Membranes were washed with PBS/
Tween (PBS with 0.05% Tween 20) and incubated for 1 h in
blocking buffer (5% of nonfat dry milk in PBS/Tween except
10% of nonfat dry milk for Nurr1 and supplemented with 5%
FBS for BDNF) at room temperature to block nonspecific bind-
ing. Blots were washed and incubated overnight at 4 °C with
primary antibodies against CREB, phospho-Ser133-CREB, and
Nur77 from Cell Signaling; Nurr1 and NOR-1 from Abcam;
BDNF from Santa Cruz Biotechnology; GAPDH from Ambion
Inc.; and actin from Sigma-Aldrich, diluted (1:1000 for all,
except GAPDH and actin 1:40,000) in blocking buffer or PBS/
Tween with 0.1% BSA and 2% nonfat dry milk for BDNF. Blots
were then washed and incubated for 1 h at room temperature
with horseradish peroxidase-conjugated secondary antibodies
(BD Biosciences) diluted 1:3000 in blocking buffer. Immunore-
active bandswere visualized using the ECLTMWestern blotting
detection reagent (Amersham Biosciences, Uppsala, Sweden)
and quantified by a computer-assisted densitometer. Actin and
GAPDH were used as loading controls.
Immunohistochemistry—Cerebella of P9, P14, P26, and adult
rats were fixed for 24 h with 4% paraformaldehyde in PBS at
4 °C and embedded in paraffin. 5-m sections were processed
for Nurr1 labeling. Briefly, sections were rehydrated and
washed twice in TBS. Endogenous peroxidase activity was inac-
tivated with 3%H2O2 in TBS. After extensive washes with TBS/
Tween (TBS with 0.5% Tween), the sections were incubated in
blocking solution (TBS/Tween with 10% FBS). Subsequently,
the sections were exposed to Nurr1 antibody (1:200 in blocking
solution; Abcam) for at least 12 h at 4 °C. The sections were
again rinsed extensively in TBS/Tween and incubated with
anti-mouse antibody coupled to biotin (1:200 in blocking solu-
tion; Vector Laboratories) for 1 h at room temperature. After
rinsing, the sections were incubated with streptavidin-peroxi-
dase in TBS (1:300; Vector laboratories). Peroxidase was devel-
oped with 0.05% diaminobenzidine in TBS and 0.035% H2O2
solution. Nuclei were stained by incubation with hematoxylin
for 1 min. Sections were dehydrated and covered with DPX
medium. Pictures were obtained in a NIKON Eclipse 901
microscope/Nikon digital sight camera, using 2, 10, 20,
and 40 objective lens.
Gene Expression Analysis—CGCs were plated in K5 and
treated or not at 2 DIV with NMDA (100 M). After 3 and 8 h,
RNA extraction was done with the RNeasy Protect kit (Qia-
gen), and samples were sent to the genomic service of the
Vall d’Hebron Hospital Research Institute to perform the
Affymetrix Rat Genome 430 2.0 array. Expression data were
obtained using the GCOS software and normalized with robust
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multichip average. The LIMMApackagewas used for statistical
analysis to identify up- and down-regulated genes using a mul-
tiple test-adjusted p value0.2. For geneswithmultiple probes,
we selected the most informative probe showing the lowest p
value. The up-regulated genes at 8 h with an increase over
2-fold and a p value0.05 were submitted to functional anno-
tation analysis with the DAVID program (david.abcc.ncifcrf-
.gov). Filters used in the functional annotation cluster were:
Similarity Term overlap 6; Similarity threshold 0.70, and Clas-
sification initial groupmembership 5.Hierarchical clustering of
the Affymetrix data was performed with the Cluster software
(version 3.0) and represented with TreeView software. The
clustering algorithm (unweighted pair group method with
arithmetic mean) was used in a centroid linkage fashion on the
probes showing an at least 1-fold change, after being centered
to the median.
Reverse Transcription-Polymerase Chain Reaction (RT-
PCR)—Total RNA was extracted from CGCs at the indicated
times after treatment with TRIzol (Invitrogen) according to the
manufacturer’s instructions. 1 g of total RNA was converted
to first strand cDNA using the SuperScriptTM II reverse tran-
scriptase protocol (Invitrogen) following the manufacturer’s
instructions. The resulting cDNA was subjected to PCR analy-
sis. PCR cycling parameters were as follows: 94 °C for 2 min for
one cycle followed by 94 °C for 30 s, 60 °C for 30 s, and 72 °C for
30 s for 35 cycles and 72 °C for 2 min. The PCR products were
stainedwith SYBR SafeTM (Invitrogen). A sample without RNA
was always negative; neonatal rat brain RNAwas used as a pos-
itive control for the products (results not shown). The actual
sequences of specific primers are as follows: Nr4a1/Nur77
(sense) 5-CAC CTT CCT ATA CCA GCT GC-3; (antisense)
5-GAA GGA GAA GAA GGT TGG AG-3; Nr4a2/Nurr1
(sense) 5-CCT TCA CAA CTT CCA CCA GA-3; (antisense)
5-AAC ACC GTA ATG CTG ACA GG-3; Nr4a3/Nor1
(sense) 5-CCT GAT TCTGGAGAGCAG TG-3; (antisense)
5-GGCGGAGACTGCTTGAAGTA-3; 18s (sense) 5-TCA
AGA ACG AAA GTC GGA GG-3 (antisense) 5-GGA CAT
CTA AGG GCA TCA CA-3. They were used at a concentra-
tion of 0.5 M.
RNA Interference—Constructs for RNA interference exper-
iments were obtained into the pSUPER.retro.puro plasmid
(OligoEngine) using specific oligonucleotides of the Nurr1
and Creb sequence and the scrambled sequence of the oligo-
nucleotide of Nurr1_1, which was used as a control and does
not recognize any rat coding sequence, indicated by capital
letter, as follows: shRNA Nurr1_1 (forward) gatccccCCAT-
TAAGGTAGAAGACATttcaagagaATGTCTTCTACCTT-
AATGGttttt, (reverse) agctaaaaaCCATTAAGGTAGAAG-
ACATtctcttgaaATGTCTTCTACCTTAATGGggg; shRNA
Creb_1 (forward) gatccccCTGAAGAAGCAGCACGAAAtt-
caagagaTTTCGTGCTGCTTCTTCAGttttt, (reverse) agcta-
aaaaCTGAAGAAGCAGCACGAAAtctcttgaaTTTCGTGC-
TGCTTCTTCAGggg; shRNA Creb_2 (forward) gatccccGC-
AAGAGAATGTCGTAGAAttcaagagaTTCTACGACATTCT-
CTTGCttttt, (reverse) agctaaaaaGCAAGAGAATGTCGTAGA-
AtctcttgaaTTCTACGACATTCTCTTGCggg; shRNA scNurr1
(forward), gatccccAGCGAAAAACTTTATCGGAttcaagagaTC-
CGATAAAGTTTTTCGCTttttt, (reverse) agctaaaaaAGCGAA-
AAACTTTATCGGAtctcttgaaTCCGATAAAGTTTTTCGCT-
ggg. Oligonucleotides were obtained from Invitrogen and were
clonedbetweenBglII/HindIII sites of pSUPER.retro.puroplasmid.
Lentiviral constructs were achieved by digesting EcoRI-ClaI sites
from pSUPER-sh to replace H1 promoter with H1-shRNA cas-
sette in pLVTHM.
Lentiviruses were propagated using methods described pre-
viously (24) (25). Briefly, human embryonic kidney 293T
(HEK293T) cells were seeded at a density of 2.5  106 cells in
100-mm dishes. The following day, cells were transfected with
20g of pLVTHM-derived constructs, 15g of pSPAX2, and 8
g of pMD2G.The transfectionwas routinely performed by the
calcium phosphate transfection method (26). Cells were
allowed to produce lentiviruses for 48 h. After 48 h, themedium
was centrifuged at 1200 g for 5 min, and the supernatant was
concentrated at 141,000 g for 120 min and then resuspended
in 50 l of PBS containing 1% BSA and stored at 80 °C. Bio-
logical titers of the viral preparations expressed as a number of
transducing units per milliliter were determined by transduc-
ing HEK293T cells in limiting dilutions. After 72 h of incuba-
tion, the percentage of green fluorescent protein (GFP)-positive
cells was determined by cytometer, and viruses were used in the
experiments at 1 106 transducing units/ml.
Lentiviral infectionwas performed at the day of plating. Cells
remained in contact with lentivirus for 5 h, and then medium
was replaced with Eagle’s basal medium and 5 or 25 mM KCl
supplemented with 10% FBS, 25,000 units of penicillin, and 25
mg of streptomycin. More than 75% of neurons were infected.
At 2 DIV, treatments were performed as described before, and
chromatin condensation was assessed at 7 DIV, respectively.
Cell lysates were obtained 30 h after treatment.
PlasmidConstructs—Rat genomicDNAwas used as the tem-
plate for PCR to amplify the Nurr1 promoter fragment, con-
taining the CREB-response element reported in Ref. 27, with
the forward primer A (5-AAGAGCTCGAGAGTTACAGTC-
ACGGGA-3) and the reverse primer B (5-AACTCGAGGG-
CTTCAGCCGAGTGATTGG-3). The fragment was cloned
into the SacI and XhoI sites of pGL3-Basic luciferase reporter
vector (pGL3-Basic) to generate plasmid pGL3-Nurr1pro-
moter. The plasmids construct was confirmed by sequencing.
Transfection and Luciferase Assay—CGCs were plated and
infected with the indicated lentivirus, and at 1 DIV, they were
transfected using Lipofectamine 2000 (Invitrogen) with pGL3-
Basic or pGL3-Nurr1promoter. For luciferase assays, 0.75g of
each pGL3 vector and 0.25 g of Renilla plasmid were trans-
fected in each 24-well plate well.
At 2 DIV, cells were treated with NMDA (100 M). 6 h after
treatment, cells were washed twice with cold PBS and were
lysed with 100 l of lysis buffer (Promega). 30 l of cell extract
were used for a luciferase reporter assay (Dual-Luciferase
reporter assay system, Promega). Data are given asmean S.E.
of values obtained in three independent experiments per-
formed in duplicate.
Chromatin Immunoprecipitation—CGCs were plated in K5
and treatedwithNMDA (100M) orK25 at 2DIV.After 90min
or 3 h, cells werewashedwith PBS and fixedwith formaldehyde.
Cells were then lysed and sonicated. 2.5 g of soluble chroma-
tin were co-immunoprecipitated with 0.5 l of phospho-
Nurr1Mediates CGCs Survival by NMDA
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Ser133-CREB antibody (Cell Signaling), Nurr1 antibody
(Abcam), or rabbit IgG (Santa Cruz Biotechnology). After de-
cross-linking of the DNA, samples were subjected to quantita-
tive real-time PCR (Q-RT-PCR). Q-RT-PCRwas performed on
a LightCycler 480 II System using LightCycler 480 SYBRGreen
mix (Roche Applied Science). Reactions were carried out in
triplicate, and Q-RT-PCR data were analyzed using the stand-
ard curve method. The primers used were: Nurr1 forward,
5-AAGTGGGCTACCAAGGTGAA-3, reverse, 5-CTGC-
CAACATGCACCTAAAG-3; and Bdnf promoter IVa for-
ward, 5-CAAAGCATGCAATGCCCTGGAA-3, and reverse,
5-CGGCAGCGCGAGCAGTCCTCT-3, which amplify re-
gions containing CREB binding sites, and Bdnf promoter
III forward, 5-GCCTGCCCTAGCCTTTACTT-3, reverse,
5-GCCAAGCTGTCTACCTGGAT-3; and Bdnf promoter
IVb forward, 5-CTCCCACAGAACTTGGGTGT-3, reverse,
5-AGGAACCCTACTCCCCTCAA-3, which amplify regions
containing putative Nurr1 binding sites. Results are shown as
the mean S.E. of three independent experiments.
Statistical Analysis—Statistical significance was determined
by one-way analysis of variance followed by Tukey’s multiple
comparison test. A value of p 0.05 was considered as statisti-
cally significant.
RESULTS
NMDA-mediated Changes in Gene Expression—NMDA
receptor stimulation rescues neurons from apoptosis through
activation of several pathways that would finally modulate the
activity of transcription factors (13, 28, 29). To analyze
changes in gene expression induced by NMDA in CGC cul-
tures, we extracted RNA from K5 cultures treated or not
with the glutamatergic agonist for 3 or 8 h at 2 DIV, and a
gene expression analysis was performed with the Affymetrix
platform rat genome 430 2.0 array. Expression data were
obtained using GCOS software and normalized with robust
multichip average. Statistical analysis was done with the
LIMMA package to identify up- and down-regulated genes
versus control conditions (K5). We considered that a gene
was up-regulated or down-regulated if its expression was
1.5 larger or smaller than in control condition (false dis-
covery rate 0.2).
After exposure toNMDA,wedetected 44 up-regulated genes
and 7 down-regulated genes at 3 h (Fig. 1A and supplemental
Table I). 188 up-regulated genes and 112 down-regulated were
detected at 8 h (Fig. 1A and supplemental Table II). Moreover,
we observed that almost 50% of the genes up-regulated at 3 h
were still up-regulated at 8 h and that six of the seven down-
regulated genes at 3 h had also a reduced expression at 8 h
(supplemental Tables I and II).
To determine the meaning of the expression changes, we
performed a functional annotation analysis of the data
obtained at 3 and 8 h using the DAVID program (data not
shown, Fig. 1B and supplemental Table III). At 3 h, the most
enriched functions and categories were related to transcrip-
tional activity and nuclear localization. By contrast, at 8 h,
the expression changes reflected a more complex situation,
having an enrichment of functions such as neurogenesis,
FIGURE 1.Gene expressionprofilingofNMDAtreatment inCGCs.CGCswereplated in KCl 5mM (K5) and treatedor not at 2DIVwithNMDA (100M). After 3 and
8h,RNAextractionwasdone, andsampleswere subjected to theAffymetrixRatGenome4302.0array. TheLIMMApackagewasused for statistical analysis to identify
up- and down-regulated genes using a multiple test (adjusted p value0.2). A, table of the up- and down-regulated genes at 3 and 8 h classified by -fold change
increaseor decrease (FC -fold change).B, pie charts representing theontological analysis of theup-regulatedgenes at 8. Themost enrichedprogramsaredetailed.
C, heatmap of the up- and down-regulated genes at 8 h. Representative genes of the synaptic transmission and antiapoptotic programs are shown.
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synaptic transmission, or development as well as ionic
metabolism and antiapoptotic program (Fig. 1B and supple-
mental Table III). All of them were in agreement with the
category of signal transduction and cell communication that
got the higher enrichment scores (Fig. 1B and supplemental
Table III).
A deeper analysis of the changes in gene expression indicated
that 4.8% of the up-regulated genes demonstrated at least an
increase of 5-fold in their expression, 8.5% had an increase
between 3- and 5-fold, and 86.7%were increased over 1-fold but
under 3-fold. In the case of down-regulated genes, all of them
were between 1- and 3-fold change (Fig. 1A and supplemen-
tal Table II). In the group of genes that changed their expres-
sion over 5-fold, we found protein convertase subtilisin/
kexin type 1 (Pcsk1), Vgf, FBJ murine osteosarcoma viral
oncogene homolog (Fos), Bdnf, protein kinase AMP-acti-
vated 2 noncatalytic subunit, phosphodiesterase 10A, and
the components of the Nr4a family: Nr4a1/Nur77, Nr4a2/
Nurr1, and Nr4a3/NOR-1 (supplemental Table II). In the
group of genes up-regulated over 3-fold but under 5-fold, we
found, for example, synaptotagmin V, stanniocalcin 1,
cAMP-response element modulator (Crem), myocyte
enhancer factor 2, polypeptide C (Mef2C), -aminobutyric
acid (Gaba-A) receptor, subunit  5 (Gabra5), potassium
voltage-gated channel, shaker-related subfamily member 4
(Kcna4), andmetabotropic glutamate receptor 4 (see supple-
mental Table II for further details).
Zhang et al. (30) performed an exhaustive study of the
gene expression changes in response to NMDAR stimulation
comparing the profile between the protective and the exci-
totoxic stimulation in hippocampal neurons. We compared
their results with our list of genes up-regulated at 3 h, and we
obtained a list of candidates to participate in the NMDA
prosurvival effect in our experimental model (Table l). From
this list, we chose the Nr4a subfamily members because of
their higher increase in expression, their potential role in
apoptosis, and their unknown function in NMDA-mediated
neuronal survival during cerebellum development.
Nurr1 Is Involved in NMDA-mediated Neuronal Survival—
The observed increase in gene expression of the Nr4a sub-
family members was further confirmed by RT-PCR. An
increase in Nr4a1, Nr4a2, and Nr4a3 was detected from 1 to
24 h after treatment with NMDA or K25 (Fig. 2A). However,
when the protein levels of the different members of Nr4a
family were determined, only Nr4a2/Nurr1 protein levels
showed a clear and consistent increase in response to NMDA
or K25. Nr4a1/Nur77 and Nr4a3/NOR-1 protein levels were
not increased. In fact, a clear decrease in Nr4a1 and Nr4a3
FIGURE 2.Nr4aFamilymembers areup-regulated in response toNMDA,but onlyNurr1protein levels are increased.CGCswere plated in 25mMKCl (NT)
or K5. At 2 DIV, K5 cells were treated or not with NMDA (100 M) (N) or K25 (K). A and B, at the indicated times, RNA and cell lysates were obtained. RT-PCR (A)
and Western blot (B) analyses were performed. Representative experiments are shown. Similar results were obtained in three independent experiments.
C, CGCswere plated in K5. At 1 DIV, CGCswere transfectedwith pGL3-Basic or pGL3-Nurr1-promoter vectors, and at 2 DIV, K5 neuronswere treated or notwith
NMDA (100 M) or K25. Luciferase assay was performed 6 h after the treatment. Results are the mean S.E. of values from three independent experiments
performed in duplicate., p 0.001 versus K5 pGL3-Basic; ###, p 0.001 versus NMDA pGL3-Basic; xxx, versus K25 pGL3-Basic; ***, p 0.001 versus K5
pGL3-Nurr1-promoter; **, p 0.01 versus K5 pGL3-Nurr1-promoter.
Nurr1Mediates CGCs Survival by NMDA
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was observed between 8 and 24 h after NMDA or K25 treat-
ment (Fig. 2B).
To further confirm the observed induction of Nurr1 after
NMDA treatment, we decided to analyze the activation of its
promoter in response to NMDA or K25 treatment. After 6 h
of being treated, CGCs were subjected to a luciferase assay
with a plasmid containing the Nurr1 promoter (pGL3-
Nurr1promoter). Granule neurons presented an increase of
Nurr1 promoter activity in the presence of NMDA and K25
versus K5 (Fig. 2C).
Next, we analyzed the participation of Nurr1 in the effect of
NMDA on neuronal survival by silencing its expression by
shRNA. CGCs were plated in the presence of lentivirus vectors
containing the shRNA against Nurr1 (Nurr1_1) sequence or
shRNA containing a scrambled Nurr1 sequence (scNurr1) as a
control. As shown in Fig. 3A, the presence of Nurr1_1 shRNA
reduces NMDA-mediated increase in Nurr1 protein levels.
Moreover, the prosurvival effect of NMDA was reduced in the
presence of Nurr1_1 shRNA when either cell viability or the
number of apoptotic nuclei was determined (Fig. 3,B andC). By
contrast, the presence of the Nurr1_1 shRNA did not block the
prosurvival effect of K25 (Fig. 3C).
CREB Regulates NMDA-mediated Induction of Nurr1—It is
widely supported that CREB is an important transcription fac-
tor in neuronal survival signaling. Moreover, it is also known
that NMDA activates CREB and that its activation is necessary
for NMDA-mediated neuronal survival (28, 29). Our results
confirmed that in our experimental system, NMDA activates
CREB. As shown in Fig. 4A, treatment of CGC cultures with
NMDA produced a time-dependent increase in the phospho-
rylation levels of phospho-Ser133-CREB. The increase was evi-
dent 1 h after NMDA treatment and reached its higher signifi-
cance at 8 h (Fig. 4A). We analyzed whether this activation was
accompanied with a higher activity of CREB on Nurr1 pro-
moter by performing a chromatin immunoprecipitation assay.
K5 cultures were treated at 2 DIV with NMDA or K25, and 90
min after, cells were fixed to promote the cross-linking of DNA
and proteins. A co-immunoprecipitation of the soluble chro-
matin was performed with phospho-Ser133-CREB antibody.
The products of de-cross-linking were subjected to Q-RT-PCR
with the primers flanking theNurr1 promoter that contains the
Cre binding site.We observed a clear increase in CREB binding
to the Nurr1 promoter in the presence of NMDA. An increase
in the binding was observed neither in K5 nor in K25 cultures
(Fig. 4B). Moreover, we assessed the promoter activity in the
presence of twoCREB shRNA (creb_1 and creb_2). As shown in
Fig. 4C, both shRNA were able to reduce CREB levels, with the
creb_1 shRNA having a greater effect. Accordingly, both
shRNA inhibited NMDA-mediated activation of Nurr1 pro-
moter, with the creb_1 shRNA having a greater effect reducing
the NMDA-mediated increase in Nurr1 protein levels than the
FIGURE 3.Nurr1 participates in NMDA neuroprotective effect. CGCs were
plated in the presence of shRNA against Nurr1 (Nurr1_1) or a scrambled
shRNA (scNurr1) asdescribedunder ”Experimental Procedures.“ At 2DIV, cells
were treated (or non-treated;NT) with NMDA (100M) or K25. A, upper panel,
30 h after treatment, cell lysateswereobtained and subjected toWesternblot
with Nurr1 antibody. Lower panel, quantification of Nurr1 levels of three
independent experiments are shown in the graph; *, p  0.05 versus
scNurr1. B, cell viability was assessed 7 DIV after treatment by MTT assay.
Results are shown as mean S.E. of values from three independent experi-
ments performed in triplicate *, p  0.05 versus NMDA scNurr1. C, at 7 DIV,
chromatin condensation was assayed by staining with Hoechst 33258. Con-
densed nuclei were counted and represented as percentage versus total
nuclei. Results are themean S.E. from three independent experiments per-
formed in triplicate; *, p 0.05 versus NMDA scNurr1.
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creb_2 shRNA (Fig. 4,D and E). Blockade ofCreb expression by
CREB shRNAdid notmodify the activity associated withNurr1
promoter and Nurr1 protein levels in K5 cultures (data not
shown).
Bdnf Is Regulated by Nurr1 in Response to NMDA—Several
genes have been reported to be regulated by the transcription
factor Nurr1. Most of them are related to the maturation and
maintenance of dopaminergic neurons. However, a few, such as
BDNF, vasoactive intestinal peptide (VIP), or-synuclein, have
been described to be involved in CGC survival (31–33). Thus,
we decided to explore whether one of these Nurr1 targeted
genes was related to the prosurvival effect of NMDA on CGCs.
First, we analyzed their protein levels in CGCs treated with
NMDA or K25 in comparison with K5 conditions. We did not
FIGURE 4. CREB regulates Nurr1 induction by NMDA. Neurons cultured in K5 were treated (or non-treated; NT) with NMDA (100 M) or K25 at 2 DIV.
A, phosphorylation of CREB (pCREB) and total CREB were determined by Western blot at the indicated times. Data are presented as mean  S.E. of three
independent experiments;, p 0.01 versus K5. B, recruitment of phospho-CREB to nurr1-promoter was determined 90min after treatment by ChIP assay
(see ”Experimental Procedures“). Data represent -fold enrichment (mean S.E.) versus K5 condition performed in three independent experiments; **, p 0.01
versus K5. C, D, and E, cells were plated in the presence of lentiviruses containing the indicated shRNAs and treated with NMDA at 2 DIV. Cell lysates where
obtained 30 h after treatment to determine CREB (C) or Nurr1 (E) levels. A luciferase assay ofNurr1-promoter was performed as described under ”Experimental
Procedures.“ D, 6 h after treatment. Data are shown as the mean S.E. of three or four independent experiments. **, p 0.01, and *, p 0.05 versus scNurr1.
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find any differences in VIP and -synuclein when their protein
levels were compared in the presence or absence of NMDA
(data not shown). However, we observed that although BDNF
protein levels were barely detectable in K5, NMDA dramati-
cally increased BDNF levels (Fig. 5A). This fact was in accord-
ance with the NMDA-mediated increase in Bdnf expression
observed at 3 and 8 h with the Affymetrix array platform (sup-
plemental Tables I and II). Activity-dependent Bdnf up-regula-
tion has been attributed to CREB activity (34). To check
whether CREB was involved in NMDA- and Nurr1-mediated
increase inBdnf expression,wedecided to performaChIP assay
with the Bdnf promoter IV (35), 90 min and 3 h after NMDA or
K25 treatment.Wewere unable to detect any significant differ-
ences at 90min inK25-treated cells. However, a robust increase
in CREB binding to Bdnf promoter IV was observed in K25-
treated cells after 3 h. However, we did not find differences
betweenNMDAandK5 either at 90min or at 3 h (supplemental
Fig. 1), suggesting that CREB is not the transcription factor
directly involved in NMDA-mediated activation of Bdnf
expression. Next, we assessed the levels of BDNF in the pres-
ence of Nurr1_1 shRNA to know whether NMDA-mediated
BDNF induction could be due to Nurr1. As shown in Fig. 5A,
reducing Nurr1 levels produced a reduction in BDNF protein
levels, suggesting that Nurr1 is directly involved in NMDA-
mediated induction of Bdnf expression in CGC cultures. This
suggestion was confirmed when we assessed Nurr1 binding to
Bdnf promoter IV by ChIP assay. Our results show that Nurr1
binding to Bdnf promoter IV is clearly increased in NMDA-
treated cells. No changes in Nurr1 binding were observed in
K25-treated cells (Fig. 5B). Moreover, NMDA-mediated Nurr1
binding to Bdnf promoter seems to be selective because no
binding was observed to other Bdnf promoters such as pro-
moter III (Fig. 5B).
Next, we performed a first approximation of the in vivo situ-
ation by determining the protein levels of Nurr1 and BDNF by
Western blot in cerebellum lysates at different days after birth.
We observed that both mature BDNF and Nurr1 protein levels
increased in the cerebellum during the second postnatal week
in a similar way (Fig. 5C). We went deeper in the expression
analysis of Nurr1 by performing an immunohistochemistry
analysis to know which cells were expressing Nurr1 and
whether its expression was homogeneous in all lobes of the
cerebellum. We detected Nurr1 mainly in the internal granule
layer. Moreover, the expression of Nurr1 was more evident in
the nodulus (lobe X) than in the other lobes of the cerebellum
(Fig. 6 and supplemental Fig. 2).
DISCUSSION
NMDAR stimulation is necessary for neuronal survival
and development in different cerebral areas. One example of
such NMDAR dependence is CGCs. Survival of these neu-
rons during their postnatal migration from the external
granule layer toward the internal granule layer (5, 6) requires
excitatory inputs from the mossy fibers acting through the
NMDARs of CGCs. Failure to receive mossy fibers inputs
triggers apoptotic CGC death (10, 11, 36). In culture, CGCs
are also sensitive to NMDAR stimulation for their survival.
When CGCs are cultured in nondepolarized culture medium
containing K5, the CGCs die by apoptosis (12). However, if
NMDA is added to the medium, the CGCs will survive for
several days (13).
Some studies have shown that the prosurvival effect of
NMDA is mediated by synaptic NMDAR (30, 37). It is
believed that calcium entry through synaptic NMDAR trig-
gers CREB activation (38) likely by stimulation of calmodulin
kinases and/orMEK/ERK kinase pathways (14, 39). In CGCs,
FIGURE 5. Nurr1 regulates NMDA-mediated increase in BDNF levels and
has similar expression pattern to neurotrophin during postnatal cere-
bellumdevelopment.A, CGCswere plated in the presence or absence of the
indicated shRNA and treated (or non-treated; NT) at 2 DIV with NMDA (100
M) or K25. BDNF protein levels were assessed by Western blot 30 h after
treatment. Data are from a representative experiment. Three additional inde-
pendent experiments showed similar results. B, recruitment of Nurr1 to Bdnf
promoters III and IVwasdetermined90minafter treatmentbyChIP assay (see
”Experimental Procedures“). Data represent -fold enrichment (mean  S.E.)
versus K5 condition performed in three independent experiments; **, p 
0.01 versus K5. C, protein extracts fromdifferent postnatal ages of rat cerebel-
lum were subjected to Western blot analysis to determine Nurr1 and BDNF
levels. A representative Western blot is shown. Three or four animals of each
age were analyzed and gave similar results.
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it has been suggested that the prosurvival effect of NMDAR
stimulation also needs CREB activation (19), the release of
the neurotrophin BDNF (13, 40, 41), the activation of the
PI3K/Akt/PKB pathway (18, 42), and the inactivation of
FOXO transcriptional activity (43). By contrast, the involve-
ment of the MEK/ERK pathway is highly controversial (13,
28, 40).
Because the intracellular signaling triggered by synaptic
NMDAR to promote neuronal survival is still only partially
known, we have used DNA microarrays to have a complete
picture of the NMDA-mediated differences in the transcrip-
tome. This methodology has allowed us not only to identify
single genes that could mediate the prosurvival effect of
NMDAR stimulation, but also to identify which functional
genetic modules are activated. Our ontological analysis
revealed that functional clusters related to neuronal develop-
ment as well as neurogenesis and antiapoptotic programs were
enriched in NMDA-treated cells. Accordingly, we detected up-
regulation of the 1, 2, and  subunits of the GABAA receptor
and a reduction of the catalytic subunit of calcineurin, postu-
lated to be responsible for the maturation blockade of CGCs
(44).6 Several genes, related to the development and/or survival
of CGCs, were also up-regulated in NMDA-treated cells, such
as Bdnf, neurocalcin,Vgf, and Pcsk1/3 (31, 45–49).We decided
to cross-check the list of genes that were up-regulated in
NMDA-treated CGCs at 3 h with the list of up-regulated genes
obtained by Zhang et al. (30) after an action potential-bursting
condition. From all the genes up-regulated in both conditions
(listed in Table 1), we focused our interest on the members of
the Nr4a subfamily because their role in cerebellum develop-
ment and NMDA-mediated neuroprotection was barely
unknown.Only a previous study had suggested thatNur77 pro-
tects hippocampal neurons in culture from staurosporine and
growth factor removal-induced toxicity in vitro and protects
hippocampal neurons from kainate-induced toxicity in vivo
(30). RT-PCR analysis confirmed the increase in the expression
of all the Nr4a subfamily members. However, only Nurr1 pro-
6 B. Barneda-Zahonero and J. Rodríguez-Alvarez, unpublished data.
FIGURE 6.Nurr1 expression ismainly restricted to nodulus lobe. Sagittal sections of cerebellum fromP9, P14, and P21 rats were obtained and subjected to
Nurr1 immunohistochemistry. Nurr1-increased expression during the different postnatal dayswas clearly evident in the nodulus lobe. Representative pictures
of each age are shown (10, 20, 40, and a reconstruction of whole cerebellum of each age performed with 2 photographs). The squares indicate the
magnified area (nodulus), and the arrows indicate cells positive to Nurr1 staining.
TABLE 1
Up-regulated genes in action potential bursting and at 3 h after NMDA treatment
A comparative analysis between the up-regulated genes at 3 h after NMDA treatment in CGC culture and action potential-bursting stimulation for 2 h in hippocampal
cultures (30) shows a list of CREB-dependent genes. The symbols indicate:1 1-fold change and 3-fold change;11, 3-fold change and 5-fold change;111,
5-fold change.
Gene
symbol
Reference
sequence Gene title FC at 3h
Atf3 NM_012912 Activating transcription factor 3 11
Bdnf NM_012513 Brain derived neurotrophic factor 11
Cpd NM_012836 Carboxypeptidase D 1
Crem NM_013086 cAMP responsive element modulator 11
Fos NM_022197 FBJ murine osteosarcoma viral oncogene homolog 111
Homer1 NM_031707 Homer homolog 1 (Drosophila) 11
Nfil3 NM_053727 Nuclear factor, interleukin 3 regulated 1
Nr4a1 NM_024388 Nuclear receptor subfamily 4, group A, member 1 111
Nr4a2 NM_019328 Nuclear receptor subfamily 4, group A, member 2 111
Nr4a3 NM_017352 Nuclear receptor subfamily 4, group A, member 3 111
Pcsk1 NM_017091 Proprotein convertase subtilisin/kexin type 1 11
Plagl1 NM_012760 Pleomorphic adenoma gene-like 1 1
Rem2 NM_022685 Rad- and gem-related GTP-binding protein 2 1
Snf1lk NM_021693 SNF1-like kinase 1
Vgf NM_030997 VGF nerve growth factor-inducible 11
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tein levels were consistently increased after NMDA treatment.
By contrast, Nur77 was down-regulated by NMDA in CGCs,
precluding its effect as a prosurvival factor in these cells.
Although Nurr1 is involved in the development and differ-
entiation of the midbrain dopaminergic neurons (50) and reg-
ulates genes such as tyrosine hydroxylase and dopamine trans-
porter (51), the fact is that some studies have also shown that it
controls the transcription of proteins such as theVIP (52);-sy-
nuclein, (53)); or BDNF (54), which have been related to CGC
survival (31–33, 45). These evidences suggested to us that
Nurr1 could be a putative candidate tomediate NMDAprosur-
vival action. Accordingly, Nurr1 shRNA reduced NMDA pro-
tective effect, showing that endogenousNurr1 is involved in the
prosurvival signaling triggered by NMDAR. By contrast, no
reduction was observed in the prosurvival effect of K25. As
mentioned above, Nurr1 expression is regulated by CREB in
non-neuronal and in neuronal cells (27, 55, 56). Our data show
for the first time that CREB binds to Nurr1 promoter in
response to NMDA treatment. In addition, reducing CREB lev-
els by shRNA leads to a reduction in theNurr1 promoter activ-
ity as well as a decrease of Nurr1 protein levels in NMDA-
treated neurons.
Next, we became interested in identifying the substrate/
substrates of Nurr1 that could be responsible for the prosur-
vival effect of NMDA. As mentioned above, Nurr1 has been
described to regulate the expression of Bdnf in midbrain
neurons (54), and it is known that BDNF is important in
migration and maintenance of CGCs during cerebellum
development (45, 57, 58). Moreover, BDNF has been sug-
gested tomediate NMDA prosurvival effect on CGCs (13, 40,
41). All these studies allowed us to hypothesize that Nurr1
could be responsible for NMDA-mediated regulation of
Bdnf. Our data support that possibility because: (a) silencing
Nurr1 expression by shRNA produced a decrease in BDNF
levels in NMDA-treated neurons and (b) NMDA increases
the binding of Nurr1 to Bdnf promoter IV. This binding
seems to be specific to certain Bdnf promoters because no
binding of Nurr1 to Bdnf promoter III was observed. It has
been also reported that CREB could interact with the Bdnf
promoter in cortical neurons after KCl stimulation (34). Our
results indicate that in CGCs, the interaction of CREB with
the Bdnf promoter IV is enhanced by KCl stimulation (K25),
whereas it is not enhanced by NMDA treatment (supple-
mental Fig. 1). Thus, we can conclude that in CGCs, NMDAR
stimulation triggers CREB-dependent Nurr1 activation that
results in a BDNF up-regulation. In this context, we have
observed in vivo that Nurr1 and mature BDNF levels
increase from P9 to P21, suggesting Nurr1 as a mediator of
survival of CGCs during cerebellum development. Addition-
ally, our immunohistochemistry analyses of Nurr1 localiza-
tion during cerebellum development report for the first time
a lobe-specific expression of Nurr1.
In summary, we have identified by whole genome expres-
sion profiling which neuronal genes change their expression
level when survival of CGCs is triggered by NMDAR stimu-
lation.We have characterized Nurr1 as a key mediator factor
in NMDA-dependent survival of CGCs. Nurr1 is a down-
stream target of CREB activation and is responsible of the
increase in mature BDNF expression linked to NMDA pro-
survival effect. Moreover, the histological analysis that
revealed that Nurr1 restricted expression in the nodulus
during cerebellum development opens a possibility to con-
sider Nurr1 as a regulator of cerebellar lobe functional
definition.
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Supplemental Table I. Up- and down-regulated genes by NMDA at 3 hours.  
 
 
RefSeq  Gene Title Gene Symbol FC adj.P.Val 
NM_012603 myelocytomatosis viral oncogene homolog 
(avian)  
Myc ↑ 8,6E-02 
NM_030997 VGF nerve growth factor inducible Vgf ↑↑ 2,3E-02 
NM_022236 phosphodiesterase 10A Pde10a ↑↑↑ 1,1E-01 
NM_053727 nuclear factor, interleukin 3 regulated Nfil3 ↑ 1,9E-01 
NM_017110 cocaine and amphetamine regulated transcript Cart ↑ 1,9E-01 
NM_021693 SNF1-like kinase Snf1lk ↑ 1,9E-01 
NM_012513 brain derived neurotrophic factor Bdnf ↑↑ 6,5E-02 
NM_019328 nuclear receptor subfamily 4, group A, member 
2 
Nr4a2 ↑↑↑ 1,0E-02 
NM_017352  nuclear receptor subfamily 4, group A, member 
3  
Nr4a3 ↑↑↑ 7,6E-02 
NM_131905 claudin 16 Cldn16 ↑ 1,6E-01 
NM_012912  activating transcription factor 3  Atf3 ↑↑ 1,4E-01 
NM_022211 fibroblast growth factor 5 Fgf5 ↓ 1,8E-01 
NM_022685 rad and gem related GTP binding protein 2 Rem2 ↑ 1,9E-01 
NM_013086  cAMP responsive element modulator Crem ↑↑ 3,5E-02 
XM_001061568 Rho GDP dissociation inhibitor (GDI) gamma 
(predicted) 
Arhgdig_predicted ↑ 5,0E-02 
NM_053514 lin-7 homolog a (C. elegans)  Lin7a ↑ 1,9E-01 
NM_138506 adrenergic receptor, alpha 2c Adra2c ↓ 1,1E-01 
NM_031707 homer homolog 1 (Drosophila) Homer1 ↑↑ 8,6E-02 
NM_001024371 neurocalcin delta Ncald ↑ 7,3E-02 
XM_001071842  TBC1 domain family, member 1 (predicted) Tbc1d1_predicted ↑ 1,6E-01 
XM_001065223  DiGeorge syndrome critical region gene 6 
(predicted) 
Dgcr6_predicted ↑ 1,9E-01 
XM_001068984 similar to KIAA0999 protein LOC684112 ↑ 1,9E-01 
XM_001063425 PHD finger protein 17 (predicted) Phf17_predicted ↑ 1,8E-01 
NM_022197 FBJ murine osteosarcoma viral oncogene 
homolog  
Fos ↑↑↑ 2,9E-02 
XM_001062276  similar to mKIAA1924 protein (predicted) RGD1561785_predicted ↑ 9,6E-02 
XM_001064150 hypothetical protein LOC683022 LOC683022 ↓ 1,9E-01 
XM_001061674 Embryonic ectoderm development (predicted) Eed_predicted ↑↑ 1,6E-01 
XM_001057421  prickle-like 1 (Drosophila) Prickle1 ↑ 1,6E-01 
XM_001061749 Eomesodermin LOC316052 ↑↑ 5,2E-02 
XM_001077526  similar to Protein UNQ9166/PRO28631 
precursor (predicted) 
RGD1563996_predicted ↓ 5,0E-02 
NM_001024360 NOD3-like protein nod3l ↑ 1,8E-01 
NM_012993 Nardilysin, N-arginine dibasic convertase 1 Nrd1 ↑ 1,6E-01 
NM_031559 Carnitine palmitoyltransferase 1a, liver Cpt1a ↑ 1,8E-01 
NM_001033079 solute carrier family 6 (neurotransmitter 
transporter), member 17 
Slc6a17 ↑ 1,5E-01 
NM_199253 proprotein convertase subtilisin/kexin type 9 Pcsk9 ↓ 1,1E-01 
XM_001080515  atonal homolog 7 (Drosophila) (predicted) Atoh7_predicted ↑↑ 5,0E-02 
NM_024388 nuclear receptor subfamily 4, group A, member 
1 
Nr4a1 ↑↑↑ 1,0E-02 
NM_053346 neuritin Nrn1 ↑ 1,9E-01 
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NM_012760 pleiomorphic adenoma gene-like 1 Plagl1 ↑ 1,0E-01 
NM_017091 proprotein convertase subtilisin/kexin type 1 Pcsk1 ↑↑ 1,0E-02 
NM_001037365 brain expressed X-linked 1 Bex1 ↑ 7,2E-02 
XM_001079173 Similar to Cysteine-rich protein 1 (Cysteine-rich 
intestinal protein) (CRIP) 
LOC691657 ↑ 1,9E-01 
NM_001033951 nuclear protein UKp68 Npuk68 ↑ 1,9E-01 
XM_001072139  Eukaryotic translation initiation factor 4 gamma, 
2 
Eif4g2 ↑ 1,7E-01 
NM_017086 Early growth response 3 Egr3 ↑ 1,8E-01 
XM_001080220 Hypothetical protein LOC691938 LOC691938 ↓ 1,6E-01 
NM_031123 Stanniocalcin 1  Stc1 ↑ 1,6E-01 
XM_001064328 Kinesin family member 5C (predicted) Kif5c_predicted ↑ 9,6E-02 
NM_012576 Nuclear receptor subfamily 3, group C, member 
1 
Nr3c1 ↑ 1,9E-01 
NM_012836  Carboxypeptidase D Cpd ↑ 3,5E-02 
XM_001064743  abhydrolase domain containing 8 (predicted) Abhd8_predicted ↓ 1,8E-01 
NM_001033984  Ankyrin 3, epithelial Ank3 ↑ 1,7E-01 
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Supplemental Table II. Up- and down-regulated genes by NMDA at 8 hours.  
 
RefSeq ID Gene Title Gene Symbol FC adj.P.Val 3h 
NM_017091 proprotein convertase subtilisin/kexin type 1 Pcsk1 ↑↑↑ 2.4E-03 * 
NM_001037220  synaptotagmin V Syt5  ↑↑ 5.1E-03  
NM_019328 nuclear receptor subfamily 4, group A, 
member 2 
Nr4a2 ↑↑↑ 8.1E-03 * 
NM_024388 nuclear receptor subfamily 4, group A, 
member 1 
Nr4a1 ↑↑↑ 8.1E-03 * 
NM_030997 VGF nerve growth factor inducible Vgf ↑↑↑ 8.1E-03 * 
NM_017092 TYRO3 protein tyrosine kinase 3 Tyro3 ↑↑ 1.1E-02  
NM_017214 regulator of G-protein signaling 4 Rgs4 ↑↑ 1.1E-02  
NM_001024371 neurocalcin delta Ncald ↑ 1.1E-02 * 
NM_022197 FBJ murine osteosarcoma viral oncogene 
homolog  
Fos ↑↑↑ 1.1E-02 * 
NM_012513 brain derived neurotrophic factor Bdnf ↑↑↑ 1.1E-02 * 
NM_001024360 NOD3-like protein nod3l ↑↑ 1.1E-02 * 
NM_001033079 solute carrier family 6 (neurotransmitter 
transporter), member 17 
Slc6a17 ↑↑ 1.1E-02 * 
NM_001024980 similar to hypothetical protein MGC46719 RGD1308412 ↑ 1.1E-02  
XM_001062276 similar to mKIAA1924 protein (predicted) RGD1561785_predicted ↑ 1.1E-02 * 
NM_017352  nuclear receptor subfamily 4, group A, 
member 3 
Nr4a3 ↑↑↑ 1.1E-02  
NM_184051 Protein kinase, AMP-activated, gamma 2 
non-catalytic subunit 
Prkag2 ↑↑↑ 1.1E-02  
XM_001073000 Similar to Bcl2-associated athanogene 2 LOC690038 ↑↑ 1.1E-02  
XM_001060664 hypothetical protein LOC682248 LOC682248  ↑ 1.1E-02  
NM_199253 proprotein convertase subtilisin/kexin type 9 Pcsk9 ↓ 1.1E-02  
NM_012760 pleiomorphic adenoma gene-like 1 Plagl1 ↑ 1.3E-02  
NM_012746 proprotein convertase subtilisin/kexin type 2  Pcsk2 ↑ 1.3E-02  
NM_001037365 brain expressed X-linked 1 Bex1 ↑ 1.3E-02 * 
NM_031123 Stanniocalcin 1 Stc1 ↑↑ 1.4E-02 * 
XM_001065204  similar to heterogeneous nuclear 
ribonucleoprotein methyltransferase-like 4  
LOC683275  ↑↑ 1.4E-02  
NM_017102 solute carrier family 2 (facilitated glucose 
transporter), member 3 
Slc2a3 ↑ 1.4E-02  
NM_133568 RASD family, member 2 Rasd2 ↑ 2.0E-02  
NM_022236 phosphodiesterase 10A Pde10a ↑↑↑ 2.1E-02 * 
NM_053881 protein tyrosine phosphatase, receptor type, 
N 
Ptprn ↑ 3.0E-02  
XM_001065526  G protein-coupled receptor 68 (predicted) Gpr68_predicted ↑ 3.1E-02  
NM_012971 potassium voltage-gated channel, shaker-
related subfamily, member 4 
Kcna4 ↑↑ 3.7E-02  
XM_001060522  similar to mKIAA0774 protein (predicted) RGD1562533_predicted ↓ 3.9E-02  
XM_001072382 hypothetical LOC314467 (predicted) RGD1305627_predicted ↑ 3.9E-02  
NM_001044276  candidate mediator of the p53-dependent G2 
arrest  
Rprm ↑↑ 3.9E-02  
XM_001072774 transferrin receptor  Tfrc ↑ 4.4E-02  
NM_053727 nuclear factor, interleukin 3 regulated Nfil3 ↑ 4.4E-02 * 
XM_001064328  Kinesin family member 5C (predicted) Kif5c_predicted ↑ 4.4E-02 * 
NM_012836  Carboxypeptidase D Cpd ↑ 4.4E-02 * 
NM_031707  homer homolog 1 (Drosophila) Homer1 ↑ 4.7E-02  
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XM_001081119  testis expressed gene 14 (predicted) Tex14_predicted ↓ 4.7E-02  
NM_019348 somatostatin receptor 2 Sstr2 ↓ 4.7E-02  
XM_001063271  Septin 6 (predicted) Sept6_predicted ↑ 5.0E-02  
NM_024162 fatty acid binding protein 3 Fabp3 ↑ 5.0E-02  
NM_001014149 similar to RIKEN cDNA 4631403P03 RGD1305276 ↑ 5.1E-02  
XM_001065359  methylenetetrahydrofolate dehydrogenase 
(NADP+ dependent) 1-like (predicted) 
Mthfd1l_predicted ↑ 5.1E-02  
XM_001057421  prickle-like 1 (Drosophila) Prickle1 ↑ 5.1E-02  
XM_001059193  Myosin regulatory light chain interacting 
protein (predicted)  
Mylip_predicted ↑ 5.1E-02  
NM_012993 Nardilysin, N-arginine dibasic convertase 1 Nrd1 ↑ 5.1E-02  
NM_053391 heparan sulfate (glucosamine) 3-O-
sulfotransferase 1 
Hs3st1 ↑ 5.1E-02  
XM_001080527  ryanodine receptor 3 Ryr3 ↑ 5.2E-02  
NM_031559 Non-coding RNA expressed in the brain, 
repeat sequence, clone 3  
Cpt1a ↑ 5.2E-02  
XM_001063425  PHD finger protein 17 (predicted) Phf17_predicted ↑ 5.2E-02  
XM_001064150 hypothetical protein LOC683022 LOC683022 ↓ 5.2E-02  
XM_001063356  similar to hypothetical protein FLJ20037 
(predicted) 
RGD1311381_predicted ↑ 5.4E-02  
XM_001070067  arrestin domain containing 2  Arrdc2 ↓ 5.4E-02  
NM_012769 guanylate cyclase 1, soluble, beta 3 Gucy1b3 ↑ 5.5E-02  
NM_012576 Nuclear receptor subfamily 3, group C, 
member 1 
Nr3c1 ↑ 5.5E-02 * 
NM_022685 Rad and gem related GTP binding protein 2 Rem2 ↑ 5.5E-02 * 
XM_001058806  similar to RIKEN cDNA 9330161F08 
(predicted) 
RGD1564315_predicted ↓ 5.5E-02  
XM_001080220 Hypothetical protein LOC691938 LOC691938 ↓ 5.5E-02  
XM_001077526  similar to Protein UNQ9166/PRO28631 
precursor (predicted) 
RGD1563996_predicted ↓ 5.5E-02 * 
XM_001064796  similar to Microtubule-associated 
serine/threonine-protein kinase 3  
LOC684053  ↓ 5.5E-02  
XM_001077761 similar to septin 6 LOC691335 ↑ 5.9E-02  
NM_017029 neurofilament 3, medium  Nef3 ↑ 6.1E-02  
XM_001081348 SH3 and cysteine rich domain 2 (predicted) Stac2_predicted ↑ 6.2E-02  
NM_022669 secretogranin 2 Scg2 ↑↑ 6.4E-02  
XM_001065637  peroxisome proliferative activated receptor, 
gamma, coactivator-related 1 (predicted) 
Pprc1_predicted ↑ 6.4E-02  
NM_001017503 transcription factor Pur-beta pur-beta ↓ 6.4E-02  
NM_001011966 SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily 
d, member 3 
Smarcd3 ↓ 6.6E-02  
NM_001014065 zinc finger, CCHC domain containing 12 Zcchc12 ↑ 6.6E-02  
NM_024399 aspartoacylase Aspa ↓ 6.7E-02  
NM_019343 regulator of G-protein signaling 7 Rgs7 ↑ 6.8E-02  
NM_172321 solute carrier family 6 (neurotransmitter 
transporter), member 15 
Slc6a15 ↑ 7.2E-02  
XM_001061674  Embryonic ectoderm development 
(predicted) 
Eed_predicted ↑↑ 7.2E-02 * 
NM_013086  CAMP responsive element modulator Crem ↑↑ 7.3E-02 * 
XM_001061749  Eomesodermin LOC316052 ↑ 7.3E-02 * 
NM_182816 adhesion molecule with Ig like domain 2 Amigo2 ↑ 7.3E-02  
XM_001077893  similar to RIKEN cDNA 2310042D19 RGD1304931 ↑ 7.7E-02  
NM_001012042  X Kell blood group precursor related family Xkr6 ↑ 7.7E-02  
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member 6 homolog 
NM_178097 Src-like adaptor Sla ↓ 7.7E-02  
NM_001009619 Nucleotide binding protein 1 Nubp1 ↓ 7.7E-02  
NM_031559 Carnitine palmitoyltransferase 1a, liver Cpt1a ↑ 7.8E-02 * 
NM_001007684 Kruppel-like factor 2 (lung) (predicted) Klf2_predicted ↑ 7.8E-02  
XM_001081777  similar to ataxin 2-binding protein 1 isoform 2 
(predicted) 
RGD1560070_predicted ↓ 7.8E-02  
NM_181629 small glutamine-rich tetratricopeptide repeat 
(TPR)-containing, beta 
Sgtb ↑ 7.9E-02  
XM_001080229 retinol binding protein 4, plasma Rbp4 ↑ 7.9E-02  
XM_001058142 Similar to TAFA2 protein LOC680647 ↑ 8.0E-02  
NM_031971 /// 
NM_212504 
heat shock 70kD protein 1A /// heat shock 
70kD protein 1B (mapped) 
Hspa1a /// Hspa1b ↑ 8.0E-02  
NM_199402 spermatogenesis associated 20 Spata20 ↓ 8.1E-02  
NM_031242 CDP-diacylglycerol synthase 1 Cds1 ↑ 8.3E-02  
NM_030987 Guanine nucleotide binding protein, beta 1 Gnb1 ↑ 8.4E-02  
NM_198750 cryptochrome 1 (photolyase-like) Cry1 ↑ 8.4E-02  
XM_001065852  chordin-like 2 (predicted) Chrdl2_predicted ↑ 8.4E-02  
XM_001053462  similar to TAFA5 (predicted) RGD1562115_predicted ↓ 8.8E-02  
NM_001047916  Synaptotagmin binding, cytoplasmic RNA 
interacting protein 
Syncrip ↑ 8.8E-02  
XM_001055358  similar to glyoxylate 
reductase/hydroxypyruvate reductase 
LOC680021  ↓ 8.9E-02  
XM_001072139  Eukaryotic translation initiation factor 4 
gamma, 2 
Eif4g2 ↑ 8.9E-02  
NM_053360 SH3-domain kinase binding protein 1 Sh3kbp1 ↓ 8.9E-02  
NM_022209 protein phosphatase 2 (formerly 2A), 
regulatory subunit B (PR 52), beta isoform 
Ppp2r2b ↓ 8.9E-02  
NM_024398 Aconitase 2, mitochondrial Aco2 ↑ 9.0E-02  
XM_001079868 zinc finger protein 537 (predicted) Zfp537_predicted ↓ 9.0E-02  
NM_001017453 similar to HGFL protein RGD1311203 ↓ 9.0E-02  
XM_001078877  similar to genetic suppressor element 1 
(predicted) 
RGD1562686_predicted ↓ 9.0E-02  
NM_017110 cocaine and amphetamine regulated 
transcript 
Cart ↑ 9.0E-02 * 
XM_001061568  Rho GDP dissociation inhibitor (GDI) gamma 
(predicted) 
Arhgdig_predicted ↑ 9.0E-02 * 
XM_216568 similar to immunoglobin superfamily, member 
21 
LOC684776 ↓ 9.0E-02  
NM_012731 neurotrophic tyrosine kinase, receptor, type 2 Ntrk2 ↓ 9.0E-02  
XM_001055675  similar to TBC1 domain family, member 8  LOC680133 ↑ 9.1E-02  
XM_001077434  suppression of tumorigenicity 5 (predicted) St5_predicted ↑ 9.2E-02  
XM_001065263  24-dehydrocholesterol reductase Dhcr24 ↓ 9.2E-02  
NM_053888 myelin transcription factor 1-like Myt1l ↓ 9.2E-02  
XM_001060956  Rap guanine nucleotide exchange factor 
(GEF) 4 
Rapgef4 ↓ 9.2E-02  
NM_031783 neurofilament, light polypeptide Nefl ↑ 9.3E-02  
NM_019242 interferon-related developmental regulator 1 Ifrd1 ↑ 9.3E-02  
XM_001072206  Solute carrier family 35, member F2 
(predicted) 
Slc35f2_predicted ↑ 9.3E-02  
NM_012603 myelocytomatosis viral oncogene homolog 
(avian)  
Myc ↑ 9.4E-02 * 
NM_031112 ribosomal protein S24 Rps24 ↑ 9.5E-02  
NM_022211 fibroblast growth factor 5 Fgf5 ↓ 9.6E-02  
 at UAB/FAC. M
EDICINA, on April 13, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
XM_001056692  similar to MADS box transcription enhancer 
factor 2, polypeptide C (myocyte enhancer 
factor 2C) (predicted) 
Mef2c ↑↑ 9.7E-02  
NM_001024823 GNAS complex locus Gnas ↑ 9.7E-02  
NM_001039002 similar to CG8312-PA RGD1304790 ↑ 9.7E-02  
NM_017025  lactate dehydrogenase A Ldha ↑ 9.7E-02  
NM_001013189 PQ loop repeat containing 1 Pqlc1 ↑ 9.7E-02  
NM_001007664 abhydrolase domain containing 14b Abhd14b ↓ 9.7E-02  
NM_133411 ATP-binding cassette, sub-family C 
(CFTR/MRP), member 4  
Abcc4 ↓ 9.7E-02  
NM_001039325 zinc finger, DHHC-type containing 22 Zdhhc22 ↓ 9.7E-02  
NM_013074 hypocretin (orexin) receptor 2 Hcrtr2 ↑ 9.9E-02  
NM_172041 potassium channel, subfamily K, member 2 Kcnk2 ↓ 9.9E-02  
NM_198783 hormone-regulated proliferation associated 
protein 20 
Hrpap20 ↑ 9.9E-02  
XM_001081727 hypothetical protein LOC688274 LOC688274 ↓ 9.9E-02  
NM_001007004 tubulin, alpha 4 Tuba4 ↑ 1.0E-01  
NM_013192 potassium inwardly-rectifying channel, 
subfamily J, member 6 
Kcnj6 ↓ 1.1E-01  
NM_012856  Potassium voltage gated channel, Shaw-
related subfamily, member 1  
Kcnc1 ↓ 1.1E-01  
XM_001066887 transducin-like enhancer of split 1, homolog 
of Drosophila E(spl) (predicted) 
Tle1_predicted ↑ 1.1E-01  
NM_019161  cadherin 22 Cdh22 ↑ 1.1E-01  
NM_030856 leucine rich repeat protein 3, neuronal Lrrn3 ↑ 1.1E-01  
NM_013113 ATPase, Na+/K+ transporting, beta 1 
polypeptide 
Atp1b1 ↑ 1.1E-01  
NM_031063 mevalonate kinase  Mvk ↓ 1.1E-01  
XM_001066524  similar to RIKEN cDNA B130052G07 
(predicted) 
RGD1564105_predicted ↓ 1.1E-01  
NM_053514 lin-7 homolog a (C. elegans)  Lin7a ↑ 1.1E-01 * 
XM_001081495 Histone deacetylase 5 Hdac5 ↑ 1.1E-01  
XM_001064836 POU domain, class 6, transcription factor 1 Pou6f1 ↑ 1.1E-01  
XM_001069930 laminin, beta 3 Lamb3 ↑ 1.1E-01  
NM_138708 RAB geranylgeranyl transferase, b subunit Rabggtb ↑ 1.1E-01  
NM_053820  early B-cell factor 1 Ebf1 ↓ 1.1E-01  
XM_001073833  spindle assembly 6 homolog (C. elegans) 
(predicted) 
Sass6_predicted ↓ 1.1E-01  
NM_001037554 brain expressed X-linked 4 Bex4 ↑ 1.1E-01  
NM_012686 Visinin-like 1 Vsnl1 ↑ 1.1E-01  
XM_001054307  Similar to RIKEN cDNA A930008G19 
(predicted) 
RGD1310799_predicted ↓ 1.1E-01  
NM_017295 gamma-aminobutyric acid (GABA-A) 
receptor, subunit alpha 5 
Gabra5 ↑↑ 1.1E-01  
XM_001080750 hypothetical protein LOC691995 LOC691995 ↓ 1.1E-01  
NM_138835 synaptotagmin XII Syt12 ↓ 1.2E-01  
NM_001013185 chaperone, ABC1 activity of bc1 complex like 
(S. pombe)  
Cabc1 ↓ 1.2E-01  
NM_183327 gamma-aminobutyric acid A receptor, 
gamma 2 
Gabrg2 ↑ 1.2E-01  
NM_139097 sodium channel, voltage-gated, type III, beta Scn3b ↑ 1.2E-01  
XM_001059403  Eph receptor B3 (predicted) Ephb3_predicted ↓ 1.2E-01  
NM_012988 nuclear factor I/A Nfia ↓ 1.2E-01  
XM_001073490 similar to dachshund b LOC686314 ↓ 1.2E-01  
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NM_022666 glutamate receptor, metabotropic 4 Grm4 ↑↑ 1.2E-01  
NM_053500 solute carrier family 25, member 27 Slc25a27 ↑ 1.2E-01  
NM_053585 MAP-kinase activating death domain Madd ↑ 1.2E-01  
XM_001062174 Ttk protein kinase (predicted) Ttk_predicted ↓ 1.2E-01  
NM_001014231  Solute carrier family 9 (sodium/hydrogen 
exchanger), isoform 3 regulator 1  
Slc9a3r1 ↑ 1.2E-01  
XM_001071422  similar to hypothetical protein LOC304280 ↑ 1.3E-01  
XM_001062329  similar to sphingosine kinase type 1-
interacting protein (predicted) 
RGD1311951_predicted ↑ 1.3E-01  
XM_001080134 transmembrane protein 16C (predicted) Tmem16c_predicted ↑ 1.3E-01  
XM_001066073  Similar to sterile alpha motif domain 
containing 12 (predicted) 
RGD1561402_predicted ↑ 1.3E-01  
NM_001025119 similar to TNF intracellular domain-interacting 
protein 
RGD1311487 ↑ 1.3E-01  
NM_153470 leucine zipper, putative tumor suppressor 1 Lzts1 ↑ 1.4E-01  
XM_001073412  sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 3 
F (predicted) 
Sema3f_predicted ↓ 1.4E-01  
XM_001068286  cell division cycle associated 2 Cdca2 ↓ 1.4E-01  
XM_001071720  insulin-like growth factor binding protein-like 
1 (predicted) 
Igfbpl1_predicted ↓ 1.4E-01  
NM_031763 platelet-activating factor acetylhydrolase, 
isoform Ib, alpha subunit 45kDa 
Pafah1b1 ↑ 1.4E-01  
NM_022671 one cut domain, family member 1 Onecut1 ↓ 1.4E-01  
XM_001072174  similar to RIKEN cDNA E430013E20 gene 
(predicted) 
RGD1311132_predicted ↓ 1.4E-01  
NM_130403 protein phosphatase 1, regulatory (inhibitor) 
subunit 14A 
Ppp1r14a ↓ 1.4E-01  
NM_031821 polo-like kinase 2 (Drosophila) Plk2 ↑ 1.4E-01  
NM_019344 Regulator of G-protein signaling 8 Rgs8 ↑ 1.4E-01  
NM_017217 solute carrier family 7 (cationic amino acid 
transporter, y+ system), member 3 
Slc7a3 ↑ 1.4E-01  
XR_008359 similar to selenoprotein SelM (predicted) RGD1565037_predicted ↓ 1.4E-01  
NM_138519 dickkopf homolog 3 (Xenopus laevis) Dkk3 ↑ 1.4E-01  
XM_001064688  FERM-domain-containing protein 163SCII LOC257646 ↑ 1.4E-01  
NM_022282 Discs, large homolog 2 (Drosophila) Dlgh2 ↑ 1.4E-01  
XM_233830 Similar to CG12467-PA (predicted) RGD1304935_predicted ↑ 1.4E-01  
XM_001070073  similar to FAT tumor suppressor homolog 4 
(predicted) 
RGD1564291_predicted ↑ 1.4E-01  
XM_001057585  similar to Ankyrin repeat domain protein 28 
(predicted) 
RGD1559931_predicted ↑ 1.4E-01  
NM_019238 farnesyl diphosphate farnesyl transferase 1 Fdft1 ↓ 1.4E-01  
XM_001075473  PDZ domain containing RING finger 3 
(predicted)  
Pdzrn3_predicted ↓ 1.4E-01  
NM_080688 phospholipase C, delta 4  Plcd4 ↓ 1.4E-01  
NM_001024341 similar to hypothetical protein MGC39325-
like protein 
MGC109194 ↓ 1.4E-01  
NM_130744 cytoglobin Cygb ↓ 1.4E-01  
NM_001012061 Cnksr family member 3 Cnksr3 ↑ 1.4E-01  
NM_001007691 protease, serine, 23 Prss23 ↑ 1.5E-01  
NM_080587 gamma-aminobutyric acid (GABA-A) 
receptor, subunit alpha 4 
Gabra4 ↑ 1.5E-01  
NM_021693 SNF1-like kinase Snf1lk ↑ 1.5E-01  
XM_001067009  coenzyme Q10 homolog A (yeast) 
(predicted) 
Coq10a_predicted ↑ 1.5E-01  
NM_133566 cystatin E/M Cst6 ↓ 1.5E-01  
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NM_001007641 Rho family GTPase 3 Rnd3 ↓ 1.5E-01  
NM_053851 calcium channel, voltage-dependent, beta 2 
subunit 
Cacnb2 ↑ 1.5E-01  
NM_001024991 fumarylacetoacetate hydrolase domain 
containing 1 
Fahd1 ↑ 1.5E-01  
XM_001077662  SLIT and NTRK-like family, member 1 
(predicted) 
Slitrk1_predicted ↑ 1.5E-01  
NM_001024309 similar to RIKEN cDNA C430004E15 LOC499749 ↓ 1.5E-01  
NM_013079 asparagine synthetase Asns ↑ 1.5E-01  
NM_001013094 cyclin L2 Ccnl2 ↑ 1.5E-01  
XM_001075222  EphA5 Epha5 ↑ 1.5E-01  
NM_031106  ribosomal protein L37  Rpl37  ↑ 1.5E-01  
NM_001014034  glutaminyl-tRNA synthase (glutamine-
hydrolyzing)-like 1 
Qrsl1 ↑ 1.5E-01  
XM_001053648  cytidine 5'-triphosphate synthase (predicted) Ctps_predicted ↑ 1.5E-01  
XM_001057357  similar to Iroquois-class homeodomain 
protein IRX-1 (Iroquois homeobox protein 1) 
(Homeodomain protein IRXA1) 
Irx1_predicted  ↓ 1.5E-01  
NM_001024966 sterile alpha motif domain containing 14 Samd14 ↓ 1.5E-01  
NM_017012 Glutamate receptor, metabotropic 5 Grm5 ↓ 1.5E-01  
NM_022441 activin A receptor type II-like 1 Acvrl1 ↓ 1.5E-01  
XM_001060640 CTF18, chromosome transmission fidelity 
factor 18 homolog (S. cerevisiae) (predicted) 
Chtf18_predicted ↓ 1.5E-01  
NM_130429 lymphoid enhancer binding factor 1 Lef1 ↓ 1.6E-01  
NM_031610 potassium inwardly-rectifying channel, 
subfamily J, member 3 
Kcnj3 ↑ 1.6E-01  
XM_001081783 similar to KIAA1447 protein (predicted) RGD1306500_predicted ↓ 1.6E-01  
NM_012912  activating transcription factor 3  Atf3 ↑ 1.6E-01 * 
NM_138887 heat shock protein, alpha-crystallin-related, 
B6 
Hspb6 ↑ 1.6E-01  
XM_001073157  hypothetical protein LOC686259 LOC686259  ↑ 1.6E-01  
NM_031730 potassium voltage gated channel, Shal-
related family, member 2 
Kcnd2 ↑ 1.6E-01  
XM_001076038 phosphoribosyl pyrophosphate 
amidotransferase 
Ppat ↑ 1.6E-01  
XM_001058624  similar to mKIAA1737 protein (predicted) RGD1309492_predicted ↓ 1.6E-01  
XM_001079414  core-binding factor, runt domain, alpha 
subunit 2; translocated to, 3 (predicted) 
Cbfa2t3_predicted ↓ 1.6E-01  
NM_001004069 Ng23 protein Ng23 ↓ 1.6E-01  
XM_001056498  Elastin microfibril interfacer 2 (predicted) Emilin2_predicted ↑ 1.6E-01  
XM_001077247  Similar to FLJ00414 protein (predicted) RGD1304675_predicted ↓ 1.6E-01  
XM_001079197  GTPase activating RANGAP domain-like 1 Garnl1 ↑ 1.6E-01  
NM_012893 actin, gamma 2  Actg2 ↓ 1.6E-01  
NM_181823 ras homolog gene family, member T2 Rhot2 ↑ 1.6E-01  
NM_031510 isocitrate dehydrogenase 1 (NADP+), soluble Idh1 ↓ 1.6E-01  
XM_001076847  Similar to AT motif-binding factor (predicted) RGD1560268_predicted ↓ 1.6E-01  
XM_001068102 similar to RIKEN cDNA 1700045I19 
(predicted) 
RGD1565844_predicted ↑ 1.6E-01  
XM_001060381 similar to RIKEN cDNA E130201N16 
(predicted) 
RGD1311589_predicted ↑ 1.6E-01  
NM_001037653  Far upstream element (FUSE) binding 
protein 1 
Fubp1 ↑ 1.6E-01  
XM_001054203  similar to RIKEN cDNA 4931414P19 
(predicted) 
RGD1565222_predicted ↓ 1.6E-01  
NM_053394 Kruppel-like factor 5 Klf5 ↑ 1.7E-01  
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NM_031792 sperm associated antigen 4 Spag4 ↑ 1.7E-01  
NM_053482 sperm autoantigenic protein 17 Spa17 ↓ 1.7E-01  
NM_001006966  peroxisomal delta3, delta2-enoyl-Coenzyme 
A isomerase  
Peci ↓ 1.7E-01  
NM_153468  Granzyme A  Gzma  ↓ 1.7E-01  
NM_013015 prostaglandin D2 synthase  Ptgds ↓ 1.7E-01  
XM_001062287  similar to RIKEN cDNA 4631427C17 
(predicted) 
RGD1564895_predicted ↑ 1.7E-01  
XM_001070886 similar to enoyl Coenzyme A hydratase 
domain containing 3 
LOC684538 ↓ 1.7E-01  
XM_001060505 Fibronectin type III domain containing 5 Fndc5 ↓ 1.7E-01  
NM_184050 putative aminopeptidase Fxna Fxna ↓ 1.7E-01  
NM_053346 neuritin Nrn1 ↑ 1.7E-01 * 
XM_001080615  similar to mKIAA0664 protein (predicted) RGD1307222_predicted ↑ 1.7E-01  
NM_198760 solute carrier family 16 (monocarboxylic acid 
transporters), member 6  
Slc16a6 ↑ 1.7E-01  
NM_012820 acyl-CoA synthetase long-chain family 
member 1  
Acsl1 ↑ 1.7E-01  
NM_017093 thymoma viral proto-oncogene 2 Akt2 ↓ 1.7E-01  
NM_017216 Solute carrier family 3, member 1 Slc3a1 ↑ 1.7E-01  
NM_139086 Syncollin Sycn ↓ 1.7E-01  
NM_001033888 Numb-like Numbl ↑ 1.7E-01  
NM_206847 phosphofructokinase, platelet Pfkp ↑ 1.7E-01  
XM_001076507  Similar to expressed sequence AW121567 
(predicted) 
RGD1559498_predicted ↑ 1.7E-01  
XM_001075314  citrate lyase beta like  Clybl ↓ 1.7E-01  
XM_001059692  similar to RIKEN cDNA 6330406I15 
(predicted) 
RGD1307396_predicted ↓ 1.7E-01  
NM_053949 potassium voltage-gated channel, subfamily 
H (eag-related), member 2 
Kcnh2 ↓ 1.7E-01  
NM_133603 potassium voltage-gated channel, Isk-related 
family, member 2 
Kcne2 ↑ 1.7E-01  
BC086440 midasin homolog (yeast) Mdn1 ↑ 1.7E-01  
XM_001079124  phosphatidylinositol transfer protein, 
membrane-associated 2 (predicted) 
Pitpnm2_predicted ↑ 1.8E-01  
NM_031552 adducin 3 (gamma) Add3 ↓ 1.8E-01  
XM_001080401 glycine decarboxylase (predicted)  Gldc_predicted ↓ 1.8E-01  
NM_030999 corticotropin releasing hormone receptor 1 Crhr1 ↑ 1.8E-01  
XM_001081500 similar to Dual specificity protein 
phosphatase 3 (T-DSP11) (predicted) 
RGD1560049_predicted ↑ 1.8E-01  
NM_012703 thyroid hormone responsive protein Thrsp ↓ 1.8E-01  
XM_001064743  abhydrolase domain containing 8 (predicted) Abhd8_predicted ↓ 1.8E-01  
XM_001068291  leucine rich repeat neuronal 6A Lrrn6a ↓ 1.8E-01  
NM_173337 Calcium/calmodulin-dependent protein 
kinase II inhibitor 1 
Camk2n1 ↓ 1.8E-01  
XM_001055504  cadherin 11 Cdh11 ↓ 1.8E-01  
XM_001074044  septin 8 (predicted) Sept8_predicted ↓ 1.8E-01  
NM_001034125 period homolog 1 (Drosophila) Per1 ↑ 1.8E-01  
NM_022005 FXYD domain-containing ion transport 
regulator 6 
Fxyd6 ↓ 1.8E-01  
NM_001013950 limb region 1-like homolog (mouse) Lmbr1l ↑ 1.8E-01  
XM_001079732 similar to Pinin LOC368070 ↑ 1.8E-01  
XM_001080515  atonal homolog 7 (Drosophila) (predicted) Atoh7_predicted ↑ 1.8E-01  
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NM_001025634 Similar to cDNA sequence BC006662 RGD1304748 ↓ 1.8E-01  
NM_172035 frizzled homolog 2 (Drosophila) Fzd2 ↓ 1.8E-01  
NM_032462 Calsenilin, presenilin binding protein, EF 
hand transcription factor 
Csen ↓ 1.8E-01  
XM_001073569  similar to Probable G-protein coupled 
receptor 62 (hGPCR8) (predicted) 
RGD1560166_predicted ↓ 1.8E-01  
XM_001060304 similar to Galectin-5 (RL-18) LOC682182 ↑ 1.8E-01  
NM_019357 villin 2 Vil2 ↑ 1.8E-01  
XM_001071064 SNF1-like kinase 2 (predicted) Snf1lk2_predicted ↑ 1.9E-01  
XM_001080745 p21 (CDKN1A)-activated kinase 6 (predicted) Pak6_predicted ↑ 1.9E-01  
XM_001064835  trichorhinophalangeal syndrome I (predicted) Trps1_predicted ↓ 1.9E-01  
XM_001071011 retinol dehydrogenase 13 (all-trans and 9-cis) 
(predicted) 
Rdh13_predicted ↑ 1.9E-01  
NM_199499 Leucine-rich repeat LGI family, member 4 Lgi4 ↓ 1.9E-01  
NM_033351 Fc receptor, IgG, alpha chain transporter Fcgrt ↓ 1.9E-01  
NM_053375 Hyperpolarization-activated cyclic nucleotide-
gated potassium channel 1 
Hcn1 ↑ 1.9E-01  
NM_131905 claudin 16 Cldn16 ↑ 1.9E-01  
XM_001054594  similar to hypothetical protein FLJ14503 
(predicted) 
RGD1564852_predicted ↑ 1.9E-01  
NM_022185 phosphatidylinositol 3-kinase, regulatory 
subunit, polypeptide 2 
Pik3r2 ↓ 1.9E-01  
NM_001013054 ADP-ribosylhydrolase like 1 Adprhl1 ↓ 1.9E-01  
NM_022270 solute carrier family 22 (organic cation 
transporter), member 4 
Slc22a4 ↓ 1.9E-01  
NM_053788 syntaxin 1A (brain) Stx1a ↑ 1.9E-01  
NM_134408 latrophilin 2 Lphn2 ↑ 1.9E-01  
XM_001077922 Similar to RIKEN cDNA 2610039E05 
(predicted) 
RGD1560840_predicted ↑ 2.0E-01  
XM_001062503  similar to RIKEN cDNA 2610200G18 
(predicted) 
RGD1561205_predicted ↓ 2.0E-01  
NM_031569 opioid receptor-like 1 Oprl1 ↓ 2.0E-01  
NM_001044278 Similar to ring finger protein 133 LOC681395 ↑ 2.0E-01  
NM_001014036 similar to RIKEN cDNA 1700108L22 RGD1307509 ↑ 2.0E-01  
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Supplemental Table III. Functionnal annotation cluster of up-regulated genes 
by NMDA at 8 hours. 
 
E. Score: 1.56   Signal Transduction  (Cluster 1) Nº genes   EASE FC   
GO_BP  cell communication  47 1,90E-03 1,5 
GO_BP  intracellular signaling cascade  24 9,00E-03 1,7 
GO_BP  signal transduction  39 1,30E-02 1,4 
GO_BP  cell surface receptor linked signal transduction  20 6,00E-02 1,5 
GO_MF  molecular transducer activity  22 8,20E-02 1,4 
GO_BP  G-protein coupled receptor protein signaling pathway  11 1,50E-01 1,6 
E. Score: 1.39  Neurogenesis (Cluster 2) Nº genes  EASE FC  
GO_BP  generation of neurons  10 1,80E-02 2,5 
GO_BP  cell development  22 2,10E-02 1,6 
GO_BP  neuron differentiation  9 2,30E-02 2,6 
GO_BP  neurogenesis  10 3,20E-02 2,2 
GO_BP  nervous system development  15 4,20E-02 1,8 
GO_BP  system development  26 6,40E-02 1,4 
GO_BP  neuron development  5 2,60E-01 1,9 
E. Score: 1.35  Ion binding (Cluster 3) Nº genes  EASE FC  
GO_MF  ion binding  41 1,40E-03 1,6 
GO_MF  metal ion binding  39 3,00E-03 1,5 
GO_MF  cation binding  35 1,20E-02 1,5 
GO_MF  zinc ion binding  17 8,00E-02 1,5 
KEYWORDS  zinc  13 1,40E-01 1,5 
KEYWORDS  metal-binding  18 2,30E-01 1,3 
GO_MF  transition metal ion binding  19 2,50E-01 1,2 
KEYWORDS  zinc-finger  7 4,80E-01 1,3 
E. Score: 1.32  Synaptic transmission (Cluster 4) Nº genes  EASE FC  
GO_BP  synaptic transmission  12 1,30E-02 2,3 
GO_BP  transmission of nerve impulse  12 2,90E-02 2,1 
GO_CC  synapse  8 3,90E-02 2,5 
KEYWORDS  Postsynaptic cell membrane  5 7,00E-02 3,2 
KEYWORDS  cell junction  7 1,00E-01 2,1 
KEYWORDS  synapse  6 1,10E-01 2,3 
GO_BP  cell-cell signaling  15 4,30E-02 1,7 
GO_BP  neurological system process  15 6,20E-02 1,7 
GO_BP  system process  18 1,10E-01 1,4 
GO_BP  regulation of neurotransmitter levels  5 1,10E-01 2,7 
E. Score: 1.26 Anti-apoptosis (Cluster 5) Nº genes  EASE FC  
GO_BP  cell development  22 2,10E-02 1,6 
GO_BP  negative regulation of apoptosis  8 2,30E-02 2,8 
GO_BP  positive regulation of cellular process  18 3,90E-02 1,6 
GO_BP  regulation of apoptosis  12 4,00E-02 2 
GO_BP  negative regulation of cellular process  18 4,20E-02 1,6 
GO_BP  regulation of programmed cell death  12 4,40E-02 1,9 
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GO_BP  anti-apoptosis  6 4,60E-02 3 
GO_BP  negative regulation of biological process  19 4,70E-02 1,6 
GO_BP  cell differentiation  25 5,30E-02 1,4 
GO_BP  positive regulation of cell proliferation  7 7,30E-02 2,4 
GO_BP  regulation of cell proliferation  11 7,60E-02 1,8 
GO_BP  positive regulation of biological process  18 8,60E-02 1,5 
GO_BP  cell proliferation  14 9,00E-02 1,6 
GO_BP  apoptosis  13 9,10E-02 1,6 
E. Score: 1.19 Ion metabolism (Cluster 6) Nº genes  EASE FC  
GO_MF  transporter activity  23 9,80E-03 1,7 
GO_MF  substrate-specific transmembrane transporter activity  17 1,10E-02 2 
GO_MF  substrate-specific transporter activity  19 1,90E-02 1,8 
GO_MF  alkali metal ion binding  7 2,10E-02 3,2 
GO_MF  transmembrane transporter activity  17 2,20E-02 1,8 
GO_MF  ion transmembrane transporter activity  14 3,20E-02 1,9 
GO_MF  potassium ion binding  5 4,40E-02 3,7 
GO_BP  metal ion transport  10 4,80E-02 2,1 
GO_BP  cation transport  11 5,00E-02 2 
GO_MF  gated channel activity  8 5,40E-02 2,3 
KEYWORDS  voltage-gated channel  6 5,50E-02 2,9 
GO_BP  monovalent inorganic cation transport  8 5,60E-02 2,3 
GO_MF  voltage-gated ion channel activity  6 6,20E-02 2,8 
KEYWORDS  potassium transport  5 6,60E-02 3,3 
GO_MF  cation transmembrane transporter activity  11 7,20E-02 1,8 
GO_MF  metal ion transmembrane transporter activity  8 7,70E-02 2,1 
KEYWORDS  potassium  5 8,50E-02 3 
GO_BP  transport  32 9,40E-02 1,3 
GO_BP  ion transport  13 9,80E-02 1,6 
GO_BP  establishment of localization  33 1,00E-01 1,3 
GO_MF  voltage-gated cation channel activity  5 1,00E-01 2,8 
GO_MF  ion channel activity  8 1,00E-01 2 
KEYWORDS  Ionic channel  8 1,00E-01 2 
GO_BP  potassium ion transport  5 1,10E-01 2,7 
GO_MF  substrate specific channel activity  8 1,20E-01 1,9 
GO_BP  localization  36 1,30E-01 1,2 
GO_MF  channel activity  8 1,30E-01 1,9 
GO_MF  passive transmembrane transporter activity  8 1,30E-01 1,9 
KEYWORDS  ion transport  10 1,50E-01 1,6 
KEYWORDS  transport  18 1,60E-01 1,4 
GO_MF  cation channel activity  6 2,00E-01 1,9 
E. Score: 1.09 Development (Cluster 7) Nº genes  EASE FC  
GO_BP  nervous system development  15 4,20E-02 1,8 
GO_BP  developmental process  39 4,20E-02 1,3 
GO_BP  system development  26 6,40E-02 1,4 
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GO_BP  multicellular organismal process  41 7,20E-02 1,2 
GO_BP  multicellular organismal development  29 8,40E-02 1,3 
GO_BP  anatomical structure development  27 1,70E-01 1,2 
GO_BP  organ development  18 2,00E-01 1,3 
E. Score: 1.05 Membrane localization (Cluster 8) Nº genes  EASE FC  
GO_MF  substrate-specific transmembrane transporter activity  17 1,10E-02 2 
KEYWORDS  membrane  46 1,80E-02 1,3 
GO_MF  substrate-specific transporter activity  19 1,90E-02 1,8 
GO_MF  transmembrane transporter activity  17 2,20E-02 1,8 
GO_MF  ion transmembrane transporter activity  14 3,20E-02 1,9 
KEYWORDS  glycoprotein  34 3,50E-02 1,4 
GO_CC  plasma membrane part  24 4,70E-02 1,5 
KEYWORDS  transmembrane  35 5,60E-02 1,3 
GO_CC  intrinsic to plasma membrane  17 8,70E-02 1,5 
GO_CC  plasma membrane  27 9,10E-02 1,3 
GO_BP  transport  32 9,40E-02 1,3 
GO_BP  establishment of localization  33 1,00E-01 1,3 
GO_CC  membrane part  45 1,20E-01 1,2 
GO_CC  integral to plasma membrane  16 1,30E-01 1,4 
GO_CC  integral to membrane  39 1,50E-01 1,2 
GO_CC  intrinsic to membrane  39 1,60E-01 1,2 
KEYWORDS  transport  18 1,60E-01 1,4 
KEYWORDS  transmembrane protein  11 1,90E-01 1,5 
GO_CC  membrane  51 3,20E-01 1,1 
E. Score: 0.84 Signalling pathways (Kinase regulation, Cluster 9) Nº genes  EASE FC  
GO_BP  MAPKKK cascade  6 5,00E-02 3 
GO_BP  protein kinase cascade  9 5,90E-02 2,1 
GO_BP  regulation of catalytic activity  9 1,20E-01 1,8 
GO_BP  positive regulation of catalytic activity  6 1,60E-01 2,1 
GO_BP  regulation of a molecular function  9 1,90E-01 1,6 
GO_BP  regulation of protein kinase activity  5 2,50E-01 2 
GO_BP  regulation of kinase activity  5 2,60E-01 1,9 
GO_BP  regulation of transferase activity  5 2,80E-01 1,8 
E. Score: 0.78 Metabolic processes (Cluster 10) Nº genes  EASE FC  
GO_BP  glucose metabolic process  5 6,60E-02 3,2 
GO_BP  hexose metabolic process  5 1,30E-01 2,6 
GO_BP  monosaccharide metabolic process  5 1,30E-01 2,5 
GO_BP  cellular carbohydrate metabolic process  6 2,30E-01 1,8 
GO_BP  carbohydrate metabolic process  7 2,70E-01 1,6 
GO_BP  alcohol metabolic process  6 2,80E-01 1,7 
E. Score: 0,78 Second messengers transduction (Cluster 11) Nº genes  EASE FC  
GO_BP  second-messenger-mediated signaling  8 6,30E-02 2,2 
GO_BP  G-protein coupled receptor protein signaling pathway  11 1,50E-01 1,6 
KEYWORDS  transducer  6 5,10E-01 1,3 
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E. Score:0.74  Receptor Activity (Cluster 12) Nº genes  EASE FC  
GO_BP  cell surface receptor linked signal transduction  20 6,00E-02 1,5 
GO_MF  signal transducer activity  22 8,20E-02 1,4 
GO_MF  molecular transducer activity  22 8,20E-02 1,4 
PATHWAY  Neuroactive ligand-receptor interaction  6 1,80E-01 1,9 
GO_MF  receptor activity  15 3,40E-01 1,2 
KEYWORDS  receptor  12 4,60E-01 1,2 
GO_MF  transmembrane receptor activity  9 5,50E-01 1,1 
E. Score: 0.71  Cell homeostasis (Cluster 13) Nº genes  EASE FC  
GO_BP  cellular homeostasis  8 7,60E-02 2,1 
GO_BP  chemical homeostasis  7 1,50E-01 1,9 
GO_BP  di-, tri-valent inorganic cation homeostasis  5 1,60E-01 2,4 
GO_BP  cellular di-, tri-valent inorganic cation homeostasis  5 1,60E-01 2,4 
GO_BP  cellular chemical homeostasis  6 1,60E-01 2,1 
GO_BP  cellular ion homeostasis  6 1,60E-01 2,1 
GO_BP  ion homeostasis  6 2,00E-01 1,9 
GO_BP  cation homeostasis  5 2,20E-01 2 
GO_BP  cellular cation homeostasis  5 2,20E-01 2 
GO_BP  homeostatic process  8 2,60E-01 1,5 
GO_BP  regulation of biological quality  10 7,10E-01 1 
E. Score: 0.7 Vesicles (Cluster 14) Nº genes  EASE FC  
GO_CC  vesicle  8 1,10E-01 1,9 
GO_CC  cytoplasmic vesicle  7 1,80E-01 1,8 
GO_CC  cytoplasmic membrane-bound vesicle  6 2,80E-01 1,7 
GO_CC  membrane-bound vesicle  6 3,00E-01 1,6 
E. Score: 0.68 Secretion (Cluster 15) Nº genes  EASE FC  
GO_BP  synaptic transmission  12 1,30E-02 2,3 
GO_BP  transmission of nerve impulse  12 2,90E-02 2,1 
GO_BP  secretion by cell  7 1,70E-01 1,8 
GO_BP  secretory pathway  6 2,20E-01 1,8 
GO_BP  secretion  7 3,80E-01 1,4 
GO_BP  establishment of cellular localization  11 4,90E-01 1,1 
GO_BP  cellular localization  11 5,10E-01 1,1 
GO_BP  cellular component organization and biogenesis  26 5,70E-01 1 
GO_BP  intracellular transport  5 9,40E-01 0,7 
E. Score: 0.67 Transcription (Cluster 16) Nº genes  EASE FC  
GO_MF  sequence-specific DNA binding  11 2,60E-03 3,1 
KEYWORDS  DNA binding  7 8,90E-03 3,9 
KEYWORDS  Transcription regulation  12 5,10E-02 1,9 
KEYWORDS  Transcription  12 5,30E-02 1,9 
GO_BP  transcription from RNA polymerase II promoter  11 5,50E-02 1,9 
GO_BP  regulation of transcription, DNA-dependent  19 6,50E-02 1,5 
KEYWORDS  dna-binding  12 7,10E-02 1,8 
GO_MF  transcription factor activity  12 7,40E-02 1,8 
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GO_BP  transcription, DNA-dependent  19 9,50E-02 1,4 
GO_MF  transcription factor binding  8 9,50E-02 2 
GO_BP  RNA biosynthetic process  19 9,70E-02 1,4 
GO_MF  transcription regulator activity  16 1,00E-01 1,5 
GO_BP  positive regulation of transcription  7 1,00E-01 2,2 
GO_BP  biological regulation  48 1,10E-01 1,2 
GO_BP  regulation of transcription  19 1,20E-01 1,4 
GO_BP  
positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process  7 1,30E-01 2 
GO_BP  regulation of gene expression  20 1,40E-01 1,3 
GO_BP  
regulation of transcription from RNA polymerase II 
promoter  8 1,70E-01 1,8 
GO_BP  
regulation of nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic process  19 1,70E-01 1,3 
GO_BP  transcription  19 1,80E-01 1,3 
KEYWORDS  nucleus  21 2,00E-01 1,3 
GO_BP  regulation of cellular process  36 2,00E-01 1,2 
GO_BP  positive regulation of cellular metabolic process  7 2,40E-01 1,7 
GO_BP  regulation of biological process  40 2,60E-01 1,1 
GO_BP  positive regulation of transcription, DNA-dependent  5 2,80E-01 1,8 
GO_BP  RNA metabolic process  20 2,90E-01 1,2 
GO_BP  positive regulation of metabolic process  7 3,00E-01 1,5 
GO_BP  regulation of cellular metabolic process  19 3,70E-01 1,2 
GO_BP  regulation of metabolic process  20 3,80E-01 1,1 
GO_MF  DNA binding  15 4,10E-01 1,2 
GO_BP  gene expression  23 4,80E-01 1,1 
GO_MF  nucleic acid binding  20 6,70E-01 1 
GO_BP  
nucleobase, nucleoside, nucleotide and nucleic acid 
metabolic process  23 7,00E-01 1 
GO_CC  organelle  53 7,90E-01 0,9 
GO_BP  macromolecule metabolic process  45 8,30E-01 0,9 
GO_CC  intracellular organelle  52 8,30E-01 0,9 
GO_CC  cytoplasm  40 8,40E-01 0,9 
GO_CC  intracellular  66 8,60E-01 0,9 
GO_CC  cytoplasmic part  29 8,80E-01 0,9 
GO_BP  biopolymer metabolic process  29 9,00E-01 0,9 
GO_CC  nucleus  23 9,10E-01 0,8 
GO_CC  intracellular part  60 9,40E-01 0,9 
GO_CC  intracellular membrane-bound organelle  37 1,00E+00 0,8 
GO_CC  membrane-bound organelle  37 1,00E+00 0,8 
E. Score: 0.56 Cytoskeleton and intracellular organelle (Cluster 17) Nº genes  EASE FC  
GO_CC  cytoskeleton  13 6,90E-02 1,7 
GO_CC  cytoskeletal part  10 7,30E-02 1,9 
GO_CC  intracellular non-membrane-bound organelle  17 2,40E-01 1,3 
GO_CC  non-membrane-bound organelle  17 2,40E-01 1,3 
GO_MF  structural molecule activity  9 2,70E-01 1,4 
GO_CC  microtubule cytoskeleton  5 3,30E-01 1,7 
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GO_CC  intracellular organelle part  23 6,90E-01 1 
GO_CC  organelle part  23 7,00E-01 1 
KEYWORDS  Coiled coil  6 7,50E-01 1 
E. Score: 0.54 Cell adhesion (Cluster 18) Nº genes  EASE FC  
KEYWORDS  cell adhesion  6 5,40E-02 2,9 
GO_BP  biological adhesion  6 6,60E-01 1,1 
GO_BP  cell adhesion  6 6,60E-01 1,1 
E. Score 0.47  Extracellular space (Cluster 19) Nº genes  EASE FC  
KEYWORDS  signal  27 6,50E-02 1,4 
GO_CC  extracellular space  21 3,90E-01 1,1 
GO_CC  extracellular region  23 4,10E-01 1,1 
GO_CC  extracellular region part  21 4,60E-01 1,1 
E. Score: 0.43 Organ morphogenesis (Cluster 20) Nº genes  EASE FC  
GO_BP  organ development  18 2,00E-01 1,3 
GO_BP  organ morphogenesis  7 3,10E-01 1,5 
GO_BP  anatomical structure morphogenesis  10 8,40E-01 0,9 
E. Score: 0.38 Nucleus (Cluster 21) Nº genes  EASE FC  
GO_MF  transcription regulator activity  16 1,00E-01 1,5 
GO_CC  nucleoplasm part  5 3,70E-01 1,6 
GO_CC  membrane-enclosed lumen  8 4,90E-01 1,2 
GO_CC  organelle lumen  8 4,90E-01 1,2 
GO_CC  nucleoplasm  5 5,00E-01 1,3 
GO_CC  nuclear lumen  6 5,30E-01 1,2 
GO_CC  nuclear part  6 9,00E-01 0,8 
E. Score: 0.33 Cellular processes (Cluster 22) Nº genes  EASE FC  
GO_MF  binding  97 1,80E-02 1,1 
GO_MF  protein binding  60 1,10E-01 1,1 
GO_CC  cell part  99 3,60E-01 1 
GO_CC  cell  99 3,60E-01 1 
GO_BP  cellular process  89 7,70E-01 1 
GO_BP  macromolecule metabolic process  45 8,30E-01 0,9 
GO_CC  intracellular  66 8,60E-01 0,9 
GO_BP  biopolymer metabolic process  29 9,00E-01 0,9 
GO_CC  intracellular part  60 9,40E-01 0,9 
GO_BP  primary metabolic process  51 9,50E-01 0,9 
GO_BP  metabolic process  56 9,70E-01 0,9 
GO_BP  cellular metabolic process  49 9,80E-01 0,8 
E. Score: 0.33 Proteolysis (Cluster 23) Nº genes  EASE FC  
KEYWORDS  protease  6 3,30E-01 1,6 
GO_BP  proteolysis  8 4,30E-01 1,3 
GO_MF  peptidase activity  7 4,40E-01 1,3 
GO_MF  endopeptidase activity  5 5,10E-01 1,3 
KEYWORDS  hydrolase  10 7,20E-01 1 
E. Score: 0.29 Cell morphogenesis (Cluster 24) Nº genes  EASE FC  
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GO_BP  cell projection morphogenesis  5 3,30E-01 1,7 
GO_BP  cellular structure morphogenesis  5 8,00E-01 0,9 
GO_BP  cell morphogenesis  5 8,00E-01 0,9 
GO_BP  anatomical structure morphogenesis  10 8,40E-01 0,9 
E. Score: 0.29 Nucleotid binding (Cluster 25)  Nº genes  EASE FC  
GO_MF  GTP binding  6 1,60E-01 2,1 
GO_MF  guanyl nucleotide binding  6 1,70E-01 2 
GO_MF  purine ribonucleotide binding  14 6,70E-01 1 
GO_MF  purine nucleotide binding  14 7,30E-01 0,9 
KEYWORDS  nucleotide-binding  10 7,70E-01 0,9 
GO_MF  nucleotide binding  15 8,10E-01 0,9 
GO_MF  ATP binding  9 8,80E-01 0,8 
GO_MF  adenyl ribonucleotide binding  9 9,00E-01 0,8 
GO_MF  adenyl nucleotide binding  9 9,30E-01 0,7 
E. Score: 0.28 Catabolic processes (Cluster 26) Nº genes  EASE FC  
GO_BP  macromolecule catabolic process  5 4,80E-01 1,4 
GO_BP  catabolic process  8 4,80E-01 1,2 
GO_BP  cellular catabolic process  6 6,30E-01 1,1 
E. Score: 0.25 Phosphatase and Hydrolase activity (Cluster 27) Nº genes  EASE FC  
GO_MF  nucleoside-triphosphatase activity  6 5,30E-01 1,2 
GO_MF  pyrophosphatase activity  6 5,70E-01 1,2 
GO_MF  hydrolase activity, acting on acid anhydrides  6 5,80E-01 1,2 
E. Score: 0.21 Acid metabolic processes (Cluster 28) Nº genes  EASE FC  
GO_BP  monocarboxylic acid metabolic process  5 3,90E-01 1,6 
GO_BP  carboxylic acid metabolic process  6 7,60E-01 1 
GO_BP  organic acid metabolic process  6 7,60E-01 0,9 
E. Score: 0.11 Response to stimulus (Cluster 29) Nº genes  EASE FC  
GO_BP  response to stimulus  22 7,00E-01 1 
GO_BP  response to external stimulus  8 7,10E-01 1 
GO_BP  response to wounding  5 8,10E-01 0,9 
GO_BP  response to stress  10 8,60E-01 0,8 
E. Score: 0.08  Kinase activity (Cluster 30) Nº genes  EASE FC  
GO_MF  protein serine/threonine kinase activity  5 6,80E-01 1,1 
GO_MF  protein kinase activity  6 7,10E-01 1 
KEYWORDS  nucleotide-binding  10 7,70E-01 0,9 
GO_MF  
transferase activity, transferring phosphorus-
containing groups  8 8,10E-01 0,9 
GO_MF  kinase activity  7 8,20E-01 0,9 
GO_MF  phosphotransferase activity, alcohol group as acceptor  6 8,30E-01 0,9 
GO_BP  phosphorylation  6 8,60E-01 0,8 
GO_BP  phosphate metabolic process  7 8,80E-01 0,8 
GO_MF  ATP binding  9 8,80E-01 0,8 
GO_MF  adenyl ribonucleotide binding  9 9,00E-01 0,8 
KEYWORDS  atp-binding  6 9,20E-01 0,7 
GO_MF  adenyl nucleotide binding  9 9,30E-01 0,7 
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GO_MF  transferase activity  10 9,70E-01 0,7 
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